Cartridge holding unit
The cartridge holding unit addresses the issue of non-parallel alignment in dose delivery mechanisms by ensuring parallel alignment and secure coupling, reducing friction and jamming risks, thereby improving the efficiency and reliability of pen-type devices.
Patent Information
- Application Number
- CN202380036617.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-11-04
- Filing Date
- 2023-04-27
- Publication Date
- 2024-12-06
AI Technical Summary
Existing dose delivery mechanisms in pen-type devices, such as insulin or growth hormone therapy pens, face issues with non-parallel alignment of the barrel and piston rod, leading to increased friction and force requirements during dose delivery, which can result in jamming.
A cartridge holding unit with a cartridge container and holder that ensures parallel alignment and rigid coupling, reducing friction by maintaining axial orientation and preventing relative movement between the cartridge and piston rod.
The solution reduces the force required for dose delivery and minimizes the risk of jamming by ensuring parallel alignment and secure coupling of the cartridge and piston rod, enhancing the operational efficiency and reliability of the device.
Smart Images

Figure CN119095633A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a cartridge holding unit for a dose delivery mechanism. Background Art
[0002] Such a dose delivery mechanism can be provided in the form of a pen, and can be used, for example, for insulin therapy or growth hormone therapy. A known pen has a barrel container having a section for attaching a barrel. However, when the barrel is attached to the barrel container, the axial orientation of the barrel may be different compared to the axial orientation of the barrel container. This usually results in the axial orientation of the barrel being non-parallel to the axial orientation of the piston and piston rod used to push the drug out of the barrel during dose delivery. However, if the axial orientation of the barrel is non-parallel to the axial orientation of the piston rod and piston, the friction between the piston and the barrel is large. Therefore, a greater force is required to perform dose delivery. Summary of the invention
[0003] It is an object of the present invention to provide a cartridge holding unit which reduces the forces required to perform dose delivery. In particular, it is an object of the present invention to provide a cartridge holding unit which reduces the risk of jamming between the piston rod and the cartridge during dose delivery.
[0004] This object is met by a cartridge holding unit according to claim 1. The cartridge holding unit comprises a cartridge container which forms an outer surface of the cartridge holding unit and has an inner space, and a cartridge holder which forms a tubular holding section arranged in the inner space of the cartridge container, wherein the cartridge holder is configured to hold the cartridge, in particular firmly, parallel to the cartridge holder, and wherein the cartridge holder and the cartridge container are coupled to each other, in particular firmly, in their axial orientation.
[0005] The present invention is based on the following conception, and a tube holder is provided, and the tube holder has a tubular holding section arranged in the tube container. Under the assembled state, the tube holder keeps the tube due to the tubular holding section, so that their corresponding axial orientations are parallel to each other. In addition, the tube holder and the tube container are firmly coupled to each other, i.e., rigidly connected to each other, so that their corresponding axial orientations are parallel to each other. In other words, the tube holder is configured to keep the tube with respect to the tube holder, and relative movement cannot be arranged between them. In addition, the tube container is coupled to the tube holder, so that the tube container is kept as immovable relative to each other with respect to the tube holder. It can be seen from this that the tube and the tube container are parallel to each other, so that if the piston rod and the piston are arranged in parallel with the tube container, usually the case is so, then the tube and the piston rod and the piston are arranged in parallel. If the tube and the piston rod and the piston are arranged in parallel, the friction between the inner peripheral surface of the tube and the outer peripheral surface of the piston can be reduced, so that the required force for performing the dose delivery is reduced.
[0006] Embodiments of the cartridge holding unit are defined by the dependent claims and are described in the following disclosure.
[0007] According to one embodiment, the tube container and the tube holder are formed as two separate parts. This allows the tube container and the tube holder to be manufactured by injection molding, which allows the tube holder unit to be produced in a cost-effective manner. Alternatively, the tube container and the tube holder can be formed integrally with each other, such as by 3D printing.
[0008] According to one embodiment, the tube container and the tube holder are inseparably coupled to each other." Inseparable "means that the tube container and the tube holder cannot be separated by hand by applying the force that occurs under the situation of normal use. Alternatively, the tube container and the tube holder can be detachably coupled to each other.
[0009] According to one embodiment, the tube container and the tube holder are axially fixedly connected to each other. The tube container and the tube holder can be connected axially fixedly to each other by shape locking engagement, for example, by snap fit connection. The snap fit connection allows to assemble the tube container and the tube holder in a simple but reliable manner. In addition, the snap fit connection will also allow the tube to be kept in a disassembled state and transported to the patient, because the assembly of the tube unit can be completed by the patient without tools.
[0010] According to one embodiment, the cartridge container and the cartridge holder are securely coupled to each other in their axial orientation by a form-locking engagement, such as by a snap-fit connection.
[0011] In order to ensure that the axial orientations of the cartridge container and the cartridge holder coincide with each other, the cartridge container and the cartridge holder may each form a corresponding end surface abutting against each other. The end surface may be an annular end surface.
[0012] According to one embodiment, the cartridge holder forms an axial fixture that engages with the axial fixture of the cartridge container. For example, one of the axial fixtures, such as the fixture of the cartridge holder, is configured as a circumferentially extending groove, and another of the axial fixtures, such as the fixture of the cartridge container, is configured as a circumferentially extending rib. The groove and / or rib may extend completely circumferentially around the respective portion.
[0013] According to one embodiment, the cartridge holder and the cartridge container are rotationally fixed to each other.
[0014] According to one embodiment, the tube holder forms a rotational fixture, which engages the rotational fixture of the tube container. Through the shape fit between the rotational fixture of the tube holder and the rotational fixture of the tube container, the tube holder and the tube container can be fixed to each other in rotation. For example, one of the rotational fixtures, such as the rotational fixture of the tube holder, can be configured as a radially protruding and axially extending rib, and another in the rotational fixture, such as the rotational fixture of the tube container, can be configured as a corresponding radial and axially extending groove, for receiving this rib.
[0015] According to one embodiment, the cartridge holder forms at its proximal end a connector for attaching a needle assembly such as a pen needle, i.e. a needle connector. The needle connector may be internally or externally threaded. The needle connector may alternatively be part of a bayonet lock or a Luer lock.
[0016] According to one embodiment, the needle connector surrounds an opening at the proximal end of the cartridge holder, wherein the opening is configured to receive a cannula of a needle assembly that is fluidly connected to an interior of a cartridge inserted into the cartridge holder.
[0017] According to one embodiment, the cartridge holder forms a notch extending in the axial direction, which allows the cartridge holder to be reversibly widened to axially insert the cartridge. The notch can be configured to reversibly widen the cartridge holder to axially insert a cartridge having a protrusion on its outer peripheral surface. Such a cartridge can be a dual chamber cartridge with a bypass.
[0018] According to one embodiment, the notch extends up to the distal end of the cartridge holder. This allows the distal end of the cartridge holder to be easily widened to axially insert a cartridge having a protrusion on its outer peripheral surface.
[0019] According to one embodiment, when the cartridge holder is securely coupled to the cartridge container, a window formed in the cartridge holder is aligned with a window in the cartridge container so that a drug disposed in an at least partially transparent cartridge in the cartridge holder can be inspected through the window. The rotational securing means of the cartridge container and the cartridge holder can be configured such that they hold the cartridge container and the cartridge holder in a relative rotational position such that the window in the cartridge holder is aligned with the window in the cartridge container.
[0020] According to one embodiment, the holding section of the cartridge holder defines a cylindrical socket.Preferably, the cartridge has a cylindrical shape such that the cartridge holder and the cartridge are in areal contact with each other along the holding section of the cartridge holder.
[0021] According to one embodiment, the inner surface of the cartridge holder is generally configured to contact the cartridge region inserted into the cartridge holder. The inner surface of the cartridge holder configured to contact the cartridge region inserted into the cartridge holder preferably extends around a closed perimeter.
[0022] According to one embodiment, the tube holder forms a notch for receiving a projection of an inserted tube, such as a bypass of a dual chamber tube. The notch can be positioned circumferentially offset from the longitudinal notch of the tube holder, such as radially relative to the longitudinal notch of the tube holder. The notch can be configured as a window in a tubular holding section.
[0023] According to one embodiment, the tubular holding section may have a constant inner diameter in the axial direction in the non-deformed state. The tubular holding section may have a circular inner diameter in the axial direction in the non-deformed state. Alternatively, the tubular holding section may have a non-circular inner diameter, such as an elliptical inner diameter, so that a friction or force fit connection can be established between the deformed holding section and the cylindrical barrel.
[0024] According to one embodiment, the boundaries of the cutout are configured to surround, such as completely surround, a protrusion on the outer surface of the inserted cartridge to prevent rotation of the cartridge about its longitudinal axis and / or axial movement of the cartridge along the longitudinal axis.
[0025] According to one embodiment, the retaining section is configured to extend over at least 30%, more preferably 50%, of the longitudinal length of the inserted cartridge.This allows for a secure coupling of the cartridge to the cartridge holder such that they are securely coupled to each other in their axial orientation.
[0026] According to one embodiment, the tube holder has a connecting device for being connected to the quantitative feed mechanism. The connecting device may include a thread, such as an internal thread. Alternatively or additionally, the connecting device may include a snap-on connecting device, such as a snap-on element or an opening that can engage with the snap-on element. According to one embodiment, the tube holder may form a connecting device comprising an internal thread and at least two openings, wherein each opening may engage with the same snap-on element of the connecting section of the quantitative feed mechanism that forms the external thread corresponding to the internal thread.
[0027] According to one embodiment, the connecting device extends into the annular space between the tube holder and the tube container. Preferably, the connecting device, such as an internal thread, extends along most of the inner peripheral surface of the tube container. This allows to form the tube holding unit in a compact manner.
[0028] According to one embodiment, the cartridge container forms a gripping portion on its outer surface so that a user can hold the cartridge holding unit on the outer surface of the cartridge container, for example for rotating the cartridge container relative to the dosing mechanism.
[0029] The invention further relates to a cartridge unit comprising a cartridge holding unit according to at least one of the preceding or below mentioned embodiments and a cartridge, for example a double chamber cartridge with a bypass, inserted into the cartridge holder.
[0030] The present invention also relates to a reconstitution unit comprising:
[0031] A cartridge holding unit according to at least one of the aforementioned or hereinafter mentioned embodiments, and a connecting section of a metering mechanism, such as a piston rod guide, wherein the cartridge container forms a first thread, such as an internal thread of a connecting device, and the connecting section of the metering mechanism forms a corresponding second thread, the first thread and the second thread being engageable with each other to cause axial movement of the cartridge container relative to the connecting section of the metering mechanism by rotating the cartridge container relative to the connecting section of the metering mechanism.
[0032] According to one embodiment, the first thread is formed on the inner circumferential surface of the cartridge container and the second thread is formed on the outer circumferential surface of the connecting section of the dosing mechanism. This has the advantage that the outer circumferential surface of the cartridge container can be used by the user as a gripping surface to rotate the cartridge holding unit relative to the connecting section, for example for performing a reassembly movement.
[0033] According to one embodiment, the reconstitution unit comprises a cartridge having a protrusion, wherein the cartridge holder forms a cutout for receiving the protrusion of the cartridge and wherein the protrusion positively engages the cutout such that the cartridge is axially and / or rotationally fixed to the cartridge holder.
[0034] According to one embodiment, a space is formed between the outer circumferential surface of the cartridge holder and the inner circumferential surface of the cartridge container, so that when the cartridge holding unit or cartridge unit is mounted to the connecting section of the dosing mechanism, and / or when the connecting section of the dosing mechanism is moved relative to the cartridge holding unit or cartridge unit during use, the connecting section of the dosing mechanism can be arranged or moved in the space between the outer circumferential surface of the cartridge holder and the inner circumferential surface of the cartridge container. For example, the space between the outer circumferential surface of the cartridge holder and the inner circumferential surface of the cartridge container can be configured to be occupied by the connecting section of the dosing mechanism during reassembly. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] These and other features, aspects and advantages are described below with reference to the accompanying drawings.Throughout the drawings, like reference numerals consistently denote corresponding features.
[0036] Figure 1 An exploded view of an injection pen according to the invention is shown.
[0037] Figure 2A Shows Figure 1 A perspective view of the knob cover of an injection pen.
[0038] Figure 2B Shows Figure 2A Side view of the knob cover.
[0039] Figure 2C Shown along Figure 2B Line AA Figure 2B Cross-section view of the knob cover.
[0040] Figure 3A Shows Figure 1 Perspective view of the injection button of an injection pen.
[0041] Figure 3B Shows Figure 3A Side view of the injection button.
[0042] Figure 3C Shown along Figure 3B Line AA Figure 3B Cross-section view of the injection button.
[0043] Figure 3D Shown along Figure 3B Line BB Figure 3B Cross-section view of the injection button.
[0044] Figure 3E Shown along Figure 3B Line CC Figure 3B Cross-section view of the injection button.
[0045] Figure 4A Shows Figure 1 A perspective view of the retaining ring of an injection pen.
[0046] Figure 4B Shows Figure 4A Top view of the clasp.
[0047] Figure 4C Shows Figure 4A Side view of the retaining ring.
[0048] Figure 4D Shows Figure 4A Bottom view of the retaining ring.
[0049] Figure 5A Shows Figure 1 First perspective view of the dose setting knob of an injection pen.
[0050] Figure 5B Shows Figure 5A Second perspective view of the dose setting knob.
[0051] Figure 5C Shows Figure 5A Side view of the dose setting knob.
[0052] Figure 5D Shown along Figure 5C Line AA Figure 5A Cross-section of the dose setting knob.
[0053] Fig. 6AShows Figure 1 A perspective view of the snap-fit element of an injection pen.
[0054] Figure 6B Shows Fig. 6A Side view of the snap-fit element.
[0055] Figure 6C Shown along Figure 6B Line AA Fig. 6A A cross-sectional view of a snap-fit element.
[0056] Fig. 7A Shows Figure 1 A perspective view of the connector of an injection pen.
[0057] Figure 7B Shows Fig. 7A Bottom view of the connector.
[0058] Figure 7C Shows Fig. 7A Side view of the connector.
[0059] Fig.7D Shows Fig. 7A Top view of the connector.
[0060] Fig. 8A Shows Figure 1 First perspective view of the dose selector of an injection pen.
[0061] Figure 8B Shows Fig. 8A Bottom view of the dose selector.
[0062] Figure 8C Shows Fig. 8A Side view of the dose selector.
[0063] Fig.8D Shown along Figure 8C Line AA Fig. 8A Cross-sectional view of the dose selector.
[0064] Fig. 8E Shown along Figure 8C Line BB Fig. 8A Cross-sectional view of the dose selector.
[0065] Fig. 9 Shows Fig. 8A Second perspective view of the dose selector of .
[0066] Fig. 10A Shows Figure 1 A perspective view of the knob key of an injection pen.
[0067] Fig. 10B Shows Fig. 10A Side view of the knob key.
[0068] Fig.11A Shows Figure 1 A perspective view of the housing of an injection pen.
[0069] Fig. 11B Shows Fig.11A A side view of the housing.
[0070] Fig. 11C Shown along Fig. 11B Line AA Fig.11A A cross-sectional view of the shell.
[0071] Fig. 12A Shows Figure 1 A first side view of a dose setting sleeve of an injection pen.
[0072] Fig. 12B Shows Fig. 12A A second side view of the dose setting sleeve.
[0073] Fig. 12C Shows Fig. 12A A third side view of the dose setting sleeve.
[0074] Fig.12D Shows Fig. 12A A fourth side view of the dose setting sleeve.
[0075] Fig.12E Shows Fig. 12A Front view of the dose setting sleeve.
[0076] Fig.12F Shows Fig. 12A A first perspective view of a dose setting sleeve.
[0077] Figure 12G Shows Fig. 12A A second perspective view of the dose setting sleeve of FIG.
[0078] Fig.13A Shows Figure 1 Perspective view of the driver of the injection pen.
[0079] Fig. 13B Shows Fig.13A First side view of the drive.
[0080] Fig. 13C Shows Fig.13A Second side view of the drive.
[0081] Fig.13D Shown along Fig. 13C Line AA Fig.13AA cross-sectional view of the drive.
[0082] Fig.14A Shows Figure 1 First perspective view of the nut of the injection pen.
[0083] Fig. 14B Shows Fig.14A A second perspective view of the nut.
[0084] Fig. 14C Shows Fig.14A Side view of the nut.
[0085] Fig.14D Shown along Fig. 14C Line AA Fig.14A First cross-sectional view of a nut.
[0086] Fig.14E Shown along Fig. 14C Line BB Fig.14A A second cross-sectional view of the nut.
[0087] Fig.15A Shows Figure 1 A first side view of the piston rod guide of an injection pen.
[0088] Fig. 15B Shows Fig.15A A second side view of the piston rod guide.
[0089] Fig. 15C Shown along Fig.15A Line AA Fig.15A sectional view of the piston rod guide.
[0090] Fig.15D Shows Fig.15A A perspective view of the piston rod guide.
[0091] Fig.16A Shows Fig.15A A first longitudinal cross-sectional view of a piston rod guide.
[0092] Fig. 16B Shows Fig.15A A second longitudinal cross-sectional view of the piston rod guide.
[0093] Fig. 16C Shows Fig.15A A perspective view of the piston rod guide.
[0094] Fig.17A Shows Figure 1 Side view of the piston rod of the injection pen.
[0095] Fig. 17B Shown along Fig.17A Line AA Fig.17A Cross-section of the piston rod.
[0096] Fig. 17C Shows Fig.17A A first perspective view of the piston rod.
[0097] Fig.17D Shows Fig.17A A second perspective view of the piston rod.
[0098] Fig.18A Shows Figure 1 Perspective view of the piston disk of an injection pen.
[0099] Fig.18B Shows Fig.18A top view of a piston disk.
[0100] Fig.18C Shown along Fig.18B Line AA Fig.18A Cross-section of the piston disc.
[0101] Fig.19A Shows Figure 1 A perspective view of the dual-chamber cartridge of an injection pen.
[0102] Fig.19B Shows Fig.19A Side view of a dual chamber cartridge.
[0103] Fig.19C Shown along Fig.19B Line AA Fig.19A Cross-sectional view of a dual-chamber cylinder.
[0104] Fig. 20A Shows Figure 1 A perspective view of the cartridge container of an injection pen.
[0105] Fig. 20B Shows Fig. 20A A first side view of a cartridge container.
[0106] Fig. 20C Shows Fig. 20A A second side view of a cartridge container.
[0107] Fig.20D Shown along Fig. 20C Line AA Fig. 20A A cross-sectional view of a cartridge container.
[0108] Fig.21A Shows Figure 1 A first perspective view of the barrel key of an injection pen.
[0109] Fig. 21B Shows Fig.21A A second perspective view of the barrel key.
[0110] Fig. 21C Shows Fig.21A A first side view of a barrel key.
[0111] Fig.21D Shows Fig.21A A second side view of the barrel key.
[0112] Fig.22A Shows Fig.21A A third side view of the barrel key.
[0113] Fig. 22B Shown along Fig.22A Line AA Fig.21A Cross-sectional view of the barrel key.
[0114] Fig.23A Shows the as-delivered state Figure 1 Side view of the injection pen.
[0115] Fig. 23B Shown along Fig.23A Line AA Fig.23A Cross-sectional view of an injection pen.
[0116] Fig.24 Shown without knob cover and with some parts transparent Fig.23A Perspective view of an injection pen.
[0117] Fig.25A Shows Fig.23A Second side view of the injection pen.
[0118] Fig.25B Shown along Fig.25A Line AA Fig.23A Cross-sectional view of an injection pen.
[0119] Fig.26A Shows the reorganization state Figure 1 Side view of the injection pen.
[0120] Fig.26B Shown along Fig.26A Line AA Fig.26A Cross-sectional view of an injection pen.
[0121] Fig.27A Shows Fig.26A Second side view of the injection pen.
[0122] Fig.27B Shows Fig.26A A third side view of the injection pen.
[0123] Fig.27C Shown along Fig.27B Line AA Fig.26A Cross-sectional view of an injection pen.
[0124] Fig.28A Shown with the knob cover unfastened Figure 1 Side view of the injection pen.
[0125] Fig.28B Shown along Fig.28A Line AA Fig.28A Cross-sectional view of an injection pen.
[0126] Fig.29A shows the state at the end of the reorganization Figure 1 Side view of the injection pen.
[0127] Fig.29B Shown along Fig.29A Line AA Fig.29A Cross-sectional view of an injection pen.
[0128] Fig. 30A Shows the dose setting state Figure 1 Side view of the injection pen.
[0129] Fig. 30B Shown along Fig. 30A Line AA Fig. 30A Cross-sectional view of an injection pen.
[0130] Fig.31A Shows the injection start state Figure 1 Side view of the injection pen.
[0131] Fig.31B Shown along Fig.31A Line AA Fig.31A Cross-sectional view of an injection pen.
[0132] Fig.32A Shows the injection start state Figure 1 Another side view of the injection pen.
[0133] Fig.32B Shown along Fig.32A Line AA Fig.32A An enlarged cross-sectional view of the injection pen.
[0134] Fig.33A Shows the injection end state Figure 1 Side view of the injection pen.
[0135] Fig.33B Shown along Fig.33ALine AA Fig.33A Cross-sectional view of an injection pen.
[0136] Fig.34 A second injection pen according to the present disclosure is shown in a pre-assembled state.
[0137] Fig.35 Another view of the second injection pen is shown in a pre-assembled state.
[0138] Fig.36 An exploded view of a second injection pen is shown.
[0139] Fig.37 A longitudinal section through a second injection pen is shown in a pre-assembled state.
[0140] Fig.38 A detailed view of the distal part of the second injection pen is shown in a pre-assembled state.
[0141] Fig.39 A detailed view of the distal end of a second injection pen is shown in an assembled state during dose setting.
[0142] Fig.40 Another view of the distal end of the second injection pen is shown in the assembled state during dose setting.
[0143] Fig.41 A detailed view of the distal end of the second injection pen is shown in an assembled state during dose delivery.
[0144] Fig.42 Another view of the distal end of the second injection pen is shown in the assembled state during dose delivery.
[0145] Fig.43 A longitudinal cross-section of the dose setting elements of a first and a second injection pen is shown.
[0146] Fig.44 A perspective view of a longitudinal section of the dose setting member is shown.
[0147] Fig.45 A distal perspective view of the dose setting element is shown.
[0148] Fig.46 A proximal perspective view of the dose setting element is shown.
[0149] Fig.47 A perspective view of a third injection pen according to the present disclosure is shown.
[0150] Fig.48 An exploded view of a third injection pen is shown.
[0151] Fig.49A longitudinal cross-section of the dose delivery mechanism of a third injection pen is shown.
[0152] Fig.50 A distal perspective view of a dosing member of a third injection pen is shown.
[0153] Fig.51 A longitudinal cutaway perspective view of a dosing member of a third injection pen is shown.
[0154] Fig.52 A perspective view of the piston rod of a third injection pen is shown.
[0155] Fig.53 A distal perspective view of an extension of a third injection pen is shown.
[0156] Fig.54 Shows Fig.53 Distal view of the extension shown in .
[0157] Fig.55 Shows Fig.53 A proximal view of the extension shown in FIG.
[0158] Fig.56 A perspective view of a coupling element of a third injection pen is shown.
[0159] Fig.57 A perspective view of the bearing, piston rod, extension, coupling element and adjustment element of a third injection pen is shown.
[0160] Fig.58 A proximal perspective view of an adjustment element of a third injection pen is shown.
[0161] Fig.59 A side view of an adjustment element of a third injection pen is shown.
[0162] Fig.60 Shown along Fig.59 Radial section through the third injected adjustment element along line AA.
[0163] Fig.61 Shown along Fig.59 Radial section through the adjustment element of the third injection along line BB.
[0164] Fig.62 A perspective view of a coupling member of a third injection pen is shown.
[0165] Fig.63 A distal perspective view of the barrel of a third injection pen is shown.
[0166] Fig.64 A longitudinal cross-section of the cartridge of a third injection pen is shown.
[0167] Fig.65 A perspective view of a housing insert of a third injection pen is shown.
[0168] Fig.66 A perspective view of the connector of a third injection pen is shown.
[0169] Fig.67 A perspective view of a longitudinal section of a connector of a third injection pen is shown.
[0170] Fig.68 A side view of the third injection pen is shown in an assembled state during dose setting.
[0171] Fig.69 A side view of a third injection pen is shown in a pre-assembled state.
[0172] Fig.70 A detailed view in longitudinal section of the distal end of a third injection pen is shown in an assembled state during dose setting.
[0173] Fig.71 Another longitudinally cut detailed view of the distal end of the third injection pen is shown in an assembled state during dose setting.
[0174] Fig.72 A detailed view in longitudinal section of the distal end of a third injection pen is shown in an assembled state during dose delivery.
[0175] Fig.73 Another longitudinally cut detailed view of the distal end of a third injection pen is shown in an assembled state during dose delivery.
[0176] Fig.74 A detailed view in longitudinal section of the distal end of a third injection pen is shown in a pre-assembled state.
[0177] Fig.75 Another longitudinally cut detailed view of the distal end of a third injection pen is shown in a pre-assembled state.
[0178] Fig.76 A perspective view of a fourth injection pen according to the present disclosure is shown.
[0179] Fig.77 A side view of a fourth injection pen is shown in an assembled state during dose setting.
[0180] Fig.78 A side view of a fourth injection pen in a pre-assembled state is shown, wherein the adjustment element is in a pre-assembled position.
[0181] Fig.79 A side view of a fourth injection pen is shown in a pre-assembled state, wherein the adjustment element is in an adjustment position.
[0182] Fig.80 An exploded view of a fourth injection pen is shown.
[0183] Fig.81 A longitudinal section through the dose delivery mechanism of a fourth injection pen is shown in an assembled state during dose setting.
[0184] Fig.82 A perspective view of a coupling element of a fourth injection pen is shown.
[0185] Fig.83 Shows the line AA Fig.82 A radial cross-section of the coupling element shown in FIG.
[0186] Fig.84 A perspective view of the piston rod of a fourth injection pen is shown.
[0187] Fig.85 A proximal perspective view of an adjustment element of a fourth injection pen is shown.
[0188] Fig.86 A side view of an adjustment element of a fourth injection pen is shown.
[0189] Fig.87 Shown along Fig.86 First longitudinal section of the adjustment element along line AA in FIG.
[0190] Fig.88 Shown in perpendicular to Fig.86 Another side view of the adjustment element of the fourth injection pen in the direction of .
[0191] Fig.89 Shown along Fig.88 Second longitudinal section of the adjustment element along line BB in FIG.
[0192] Fig.90 A distal perspective view of the barrel of a fourth injection pen is shown.
[0193] Fig.91 A distal perspective view of the insert of the sleeve is shown.
[0194] Fig.92 A proximal perspective view of the insert of the sleeve is shown.
[0195] Fig.93 A distal perspective view of the outer portion of the sleeve is shown.
[0196] Fig.94 A side view of a coupling member of a fourth injection pen is shown.
[0197] Fig.95 Shown along Fig.90A longitudinal cross-sectional view of the coupling member along line AA in FIG.
[0198] Fig.96 Shown along Fig.90 A radial cross-sectional view of the coupling member along line BB in FIG.
[0199] Fig.97 A distal perspective view of a dosing member of a fourth injection pen is shown.
[0200] Fig.98 A perspective view in longitudinal section of the dosing member is shown.
[0201] Fig.99 A longitudinal cross-section of the distal end of the dose delivery mechanism of a fourth injection pen is shown in an assembled state during dose setting.
[0202] Fig.100 Another longitudinal section view of the distal end of the dose delivery mechanism of a fourth injection pen is shown in an assembled state during dose setting.
[0203] Fig.101 A longitudinal section view of the distal end of the dose delivery mechanism of a fourth injection pen is shown in an assembled state during dose delivery.
[0204] Fig.102 Another longitudinal section view of the distal end of the dose delivery mechanism of the fourth injection pen is shown in an assembled state during dose delivery.
[0205] Fig.103 A longitudinal section through the distal end of a dose delivery mechanism of a fourth injection pen is shown in a pre-assembled state, wherein the adjustment element is in a pre-assembled position.
[0206] Fig.104 Another longitudinal section through the distal end of the dose delivery mechanism of a fourth injection pen is shown in a pre-assembled state, with the adjustment element in the pre-assembled position.
[0207] Fig.105 A longitudinal section through the distal end of a dose delivery mechanism of a fourth injection pen is shown in a pre-assembled state with an adjustment element in an adjustment position.
[0208] Fig.106 Another longitudinal section through the distal end of the dose delivery mechanism of a fourth injection pen is shown in a pre-assembled state with the adjustment element in an adjustment position. DETAILED DESCRIPTION
[0209] refer to Figures 1 to 22B , describes the various parts of the injection pen 10 according to the present invention. Figures 23A to 33B Describes how the pen is intended to be used.
[0210] Figure 1 An exploded view of a drug delivery device in the form of an injection pen 10 is shown. The injection pen 10 comprises, in order from the distal end 12 to the proximal end 14: a knob cover 16, which may also be referred to as a knob lock, a cover or a retaining element; an injection button 18, which may be part of an actuating member; a snap ring 20; a dose setting knob 22, which may also be referred to as a dose setting element, a dose adjustment member or a knob, and may be part of an actuating member; a snap element 24, which may also be referred to as a dose setting device; a connector 26; a dose selector 28; a knob key 30, which may also be referred to as a clip; a housing 32, which may also be referred to as a body; a dose setting sleeve 34, which may also be referred to as a dose sleeve or a dose indicating member; a driver 36; a nut 38; a spring 40; a piston rod guide 42, which may also be referred to as a piston guide; a piston rod 44; a piston disc 46, which may also be referred to as a bearing; a dual chamber cartridge 48, which may also be referred to as a drug container, a fluid compartment or a cartridge; a cartridge container 50; and a cartridge holder or cartridge key 52. The assembly of the cartridge container 50 and the cartridge holder 52 may also be referred to as a drug container holder. Thus, the cartridge container 50 provides an outer container holder, and the cartridge key 52 provides an inner container holder of the container holder.
[0211] Although the above-mentioned parts of the injection pen 10 may each be formed as a separate part to simplify the production of the separate parts, it will generally be possible to form one or more parts integrally with each other. For example, the injection button 18, the snap ring 20 and / or the dose setting knob 22 may be integrally formed with each other. Furthermore, the dose setting sleeve 34 and the driver 36 may be integrally formed with each other. In general, even the housing 32 and the piston rod guide 42 may be integrally formed with each other.
[0212] Different parts can be grouped together to define different functional units. For example, the section between the injection button 18 and the piston rod guide 42 can be referred to as a dose setting mechanism 54, a dose setting unit, a dose delivery mechanism and / or a dose delivery activation mechanism. On the other hand, the section between the piston rod guide 42 and the barrel key 52 can be referred to as a drug reconstitution unit 56 or a reconstitution device. The barrel container 50 and the barrel holder 52 can be referred to as a barrel holding unit. The barrel container 50, the barrel holder 52 and the barrel 48 can be referred to as a barrel unit. For example, the barrel unit can be sold separately from the rest of the injection pen 10 in a pre-assembled state or as a separate part.
[0213] Next, the above-mentioned parts of the injection pen 10 are described in order starting from the distal end 12 and ending at the proximal end 14, which are opposite ends of the injection pen 10, and the proximal end 14 includes a dispensing outlet:
[0214] Figures 2A to 2CThe knob cover 16 is depicted. During delivery, i.e. shipment, of the injection pen 10 to a customer (e.g. a patient), the knob cover 16 covers the dose setting knob 22. The knob cover 16 can be completely separated from the rest of the injection pen 10. The knob cover 16 can be attached to and / or separated from the housing 32 by means of two deformable wings 58, which can be deflected outwardly, i.e. in a radial direction, to separate the knob cover 16 from the housing 32. The wings 58 form a proximal end section of the knob cover 16. On the inner surface of each wing 58, a form-fitting engagement means in the form of a lug 60 is provided, which is configured to engage with the housing 32, in particular with a radially extending coupling surface 228 formed on the piston guide 42 (see Fig. 15C ) engage to axially fix the knob cover 16 in the distal direction relative to the housing 32. Immediately adjacent to each lug 60, a window 62, i.e., a radially extending opening, is formed in the wing 58. When the knob cover 16 is attached to the housing 32, the window 62 is located at the housing 32 to form a circumferentially extending protrusion 64 (see Fig.25A ) at an axial position. On the far side of each window 62, i.e., on the side away from the lug 60, an abutment 66 is formed on the inner side surface of the corresponding wing 58. The abutment 66 has a width that is the same as the recess or cutout 68 (see FIG. 1 ) on the outer surface of the housing 32. Fig.11A ), more specifically, the width of the recess or cutout 68 in the chamfered portion 69 formed on the outer surface of the housing 32. In addition, when the knob cover 16 is attached to the housing 32, the abutment 66 forms a front surface 66a that axially abuts the radially extending surface 32a (see Fig. 11B ), the radially extending surface 32a defines the proximal end of the cutout 68. The radially extending surface 32a defines a stop surface that prevents the knob cover 16 from moving proximally relative to the housing 32, for example, in the event that the injection pen 10 falls to the floor with the distal end 12 first. To further ensure that the knob cover 16 does not move beyond its attachment position in the proximal direction 1, an axial abutment protrusion 70 (see Fig.11A The projection 70 is configured to form a gap 72 between the wings 58 (see Figure 2C ) are engaged so that the proximal front surface of the knob cover 16 abuts the distal front surface of the axially adjacent protrusion 70.
[0215] The form-fitting engagement between the abutment 66 and the cutout 68 and / or the form-fitting engagement between the protrusion 70 and the void 72 ensures that the knob cover 16 is rotationally restrained relative to the housing 32 when the knob cover 16 is attached to the housing 32 .
[0216] As from Figure 2AAs can be seen, the knob cover 16 can only be separated from the rest of the injection pen 10 by linearly moving the knob cover 16 in the distal direction. To do so, a linear recess 74 is formed on the inner circumferential surface of the knob cover 16, which corresponds to the anti-rolling device 76 in the form of an axially extending rib of the dose setting knob 22 (see Figure 5B ). Thus, the dose setting knob 22 is prevented from rotating within the knob cover 16 by the form-fitting engagement of the linear recess 74 and the anti-roll feature 76. Figure 2A As can be seen in the figure, the knob cover 16 also forms an anti-roll device 78 in the form of an axially extending rib on the outer surface of the knob cover 16. The anti-roll devices 76 and 78 ensure that the injection pen 10 and the knob cover 16 will not roll away when placed on a flat surface. Figure 2A It can also be seen that the knob cover 16 has a closed perimeter 16a and a closed face 16b at its distal end. Thus, the knob cover 16 forms a closed sleeve surrounding the distal section of the injection pen 10.
[0217] Figures 3A to 3E The injection button 18 is depicted. The injection button 18 forms a distal front surface 80 to apply a force to the injection button 18 to inject a set dose. The injection button 18 includes an axial fixing device 82 to axially attach the injection button 18 to the snap ring 20 (see Figures 4A-4D ), the collar 20 is axially connected to the dose setting knob 22 (see Figures 5A to 5D ). The axial fixing means 82 comprises two elastically deformable hooks 82 which engage with circumferentially extending ribs 84 on the snap ring 20. The snap ring 20 further comprises axial fixing means 86 in the form of elastically deformable bendable hooks which engage with undercuts 88 formed in the dose setting knob 22. The injection button 18, the snap ring 20 and the dose setting knob 22 are permanently axially fixed to each other in the assembled state of the dose delivery mechanism 54.
[0218] The injection button 18 also forms a rotational securing means 90 in the form of radially extending ribs. The ribs 90 are connected to the rotational securing means 92 in the form of teeth arranged in the inner peripheral surface of the collar 20 (see Figure 4A ) engages in a form-fitting manner to rotationally connect the injection button 18 to the collar 20. The rotational securing means 92 forms a toothed portion 93 of the collar 20, and the rib 90 forms an engagement portion of the injection button 18. The collar 20 comprises a rotational securing means 94 in the form of an axially extending recess which defines a side surface of the elastically deformable bendable hook 86 and engages with a rotational securing means 96 in the form of an axially extending rib on the inner circumferential surface of the dose setting knob 22 (see Figure 5A ) join.
[0219] After assembly and in the assembled state of the dose delivery mechanism 54 , the injection button 18 , the snap ring 20 and the dose setting knob 22 are rigidly connected to each other and form both a dose setting member and an actuation member of the dose delivery mechanism 54 .
[0220] The injection button 18 is formed into a cylindrical portion 18a. On the cylindrical portion 18a, an assembly means 98 in the form of a projection is formed to axially pre-assemble the injection button 18 with the snap element 24. More precisely, the lower, i.e. proximal assembly means 98b (see Figure 3C ) by interfering with the coupling means 102 on the snap element 24 to limit the distal movement of the injection button 18 relative to the snap element 24. The upper, i.e. distal, assembly means 98a limits the proximal movement of the injection button 18 relative to the snap element 24 by interfering with the coupling means 102 on the snap element 24 after pre-assembly, and limits the distal movement of the injection button 18 after final assembly. When the snap element 24 and the injection button 18 are pre-assembled, i.e. in a pre-assembled state, the coupling means 102 is arranged between the proximal assembly means 98b and the distal assembly means 98a. In the pre-assembled state, the injection button 18 is not yet rigidly connected to the snap ring 20 and the dose setting knob 22. However, when the coupling means 102 is arranged distally of the distal assembly means 98a, i.e. in an assembled state, the injection button 18 is rigidly connected to the snap ring 20 and the dose setting knob 22. The injection button 18 also forms a coupling means 100 in the form of a protrusion, which is arranged on an elastically inwardly bendable portion on the outer peripheral surface of the injection button 18. The inwardly bendable portion extends in the axial direction and is partially surrounded by the cutout 101.
[0221] The coupling device 100 is configured to permanently axially lock the injection button 18 after the injection is completed, and thus also lock the snap ring 20 and the dose setting knob 22 to the snap element 24, so that the injection pen 10 cannot be operated. That is, when the injection button 18 is axially moved to initiate dose delivery, the coupling device 100 is locked by the circumferentially extending flange 102 on the snap element 24 (see Fig. 6A ) in the form of a radially inwardly extending coupling device. The radially inwardly extending flange 102 causes the protrusions arranged on the elastically inwardly bendable portion 100 to bend inwardly until the protrusions pass the flange 102. In order to reduce the force required to push the protrusions 100 through the flange 102, the protrusions 100 form a chamfered outer surface 100a. Alternatively or additionally, the flange 102 may form a chamfered inner surface. When the protrusions 100 have passed the flange 102, they will spring back to their neutral position, which allows the injection button 18 to be permanently axially locked relative to the snap element 24. This feature ensures that the injection pen 10 can only be used once to inject a precise dose.
[0222] As in Figure 3C and3E As best seen in FIG. 1 , the injection button 18 includes an axially extending rib 104 on its inner circumferential surface. The axially extending rib 104 engages the nut 38 (see FIG. 1 ). Fig. 14C ) in an axially extending groove 106 to form a rotational fixing device. Due to the axially extending ribs 104 and the corresponding axially extending grooves 106, the injection button 18 and the nut 38 can move axially relative to each other, but are fixed to each other in rotation.
[0223] As in Figure 5B and 5D As can be best seen in FIG. 1 , a set of teeth 108 is formed in an axial section on the inner circumferential side of the dose setting knob 22. These teeth 108 are configured to engage with a set of teeth 110 (see FIG. 1 ) arranged in a distal section on the outer circumferential surface of the snap element 24 during dose setting. Figures 6A-6C ) engagement. Therefore, when the dose setting knob 22 is rotated during dose setting, the snap element 24 will also rotate. Fig. 6A As can be seen in the figure, the teeth 110 are only arranged in two opposite sections of the snap element 24, while the section between the two opposite sections does not form any teeth. This has advantages for the production of the injection pen 10. Alternatively, the teeth 110 can be formed along the entire circumference of the snap element 24.
[0224] The snap element 24 forms an axial section with a reduced cross section, thereby forming a coupling surface 112 for the connector 26. The connector 26 shown in the figure is formed as an integral part. However, the connector 26 can also be formed by a plurality of, for example, two parts connected to each other, for example by a form-fit connection. The connector 26 has an open cross section (see Fig.7D ), so it can be clipped onto the snap element 24 at a reduced cross-section. Since the connector 26 has a length L1 in the axial direction, which corresponds to the length L2 in the axial direction of the axial section with a reduced cross-section, the connector 26 is axially fixedly connected to the snap element 24 in both directions. However, the connector 26 can rotate relative to the snap element 24. When the dose setting knob 22 is pushed in the proximal direction 1 to start dose delivery, the teeth 108 of the dose setting knob 22 engage with a set of teeth 114 formed on the outer circumferential surface of the connector 26 instead of the teeth 110 of the snap element 24, so that the snap element 24 can rotate relative to the dose setting knob 22 during dose delivery. The engagement between the teeth 108 of the dose setting knob 22 and the teeth 114 of the connector 26 ensures that the dose setting knob 22 does not rotate relative to the housing 32 during dose delivery, because the connector 26 is rotationally fixed to the housing 32 by the dose selector 28.
[0225] The snap element 24 further comprises an engagement feature 116 in the form of an axially extending radial protrusion. The engagement feature 116 is an axially extending rib. The engagement feature 116 may have a symmetrical cross-section or an asymmetrical cross-section in a radial plane perpendicular to the longitudinal axis of the injection pen 10. The engagement feature 116 is configured to engage with dose stops 118a, 118b, 118c and 118d formed on the inner circumferential surface of the dose selector 28 (see Figure 8B ) to set the desired dose. Therefore, the engagement feature 116 serves as a dose limiting element and the engagement feature 116 together with the dose stops 118a, 118b, 118c, 118d form a dose limiting mechanism 115 of the injection pen 10. The dose limiting element 116 is located on an elastically deformable section 120, i.e. on an axially extending arm that is partially surrounded by the cutout 121. When the dose limiting element 116 passes one of the dose stops 118a, 118b, 118c and 118d, the elastically deformable section 120 bends inwardly. In order to reduce the force required to rotate the dose setting knob 22 and the snap element 24 relative to the dose selector 28 to increase or decrease the set dose, the dose stop 118 has chamfered side surfaces 122a-d and 123a-d. According to Figure 8B In the embodiment shown in , the dose stoppers 118a-d have a symmetrical cross-section in a radial plane perpendicular to the longitudinal axis of the injection pen 10. In other words, the chamfered side surfaces 122 and 123 have spacings that are equal in magnitude to each other. Fig. 9 In another embodiment shown in , the chamfered side surfaces 122a'-d' that contact the protrusion 116 to deform the elastically deformable section 120 when the dose is set to a higher dose have a smaller spacing than the chamfered side surfaces 123a'-d' that contact the protrusion 116 when the dose is set to a lower dose. The side surfaces 123a-d define a rotational position corresponding to the settable dose. The spring 40 is configured to rotate the snap element 24 relative to the dose selector 28 so that the dose limiting element 116 abuts one of the side surfaces 123a-d.
[0226] The snap element 24 further comprises a hard stop 124 in the form of an axially extending rib, which abuts a hard stop 126 formed on the dose selector 28 when the injection pen 10 is delivered to the customer. Contrary to known pens, the hard stop 126 does not correspond to a zero dose stop, but rather to a preset dose stop. Further discussion of this feature follows. The hard stop 124 is axially spaced from the dose limiting element 116, but axially aligned with the dose limiting element 116. The hard stop 124 is configured to abut an end-of-dose setting hard stop 128.
[0227] The snap element 24 also includes axial and rotational securing means in the form of radially extending openings 130 and axially extending slots 132 to axially and rotationally secure the snap element 24 to the driver 36. Fig.13A As can be seen in the drawings, the driver 36 has an axially extending rib 134, which is configured to engage with the notch 132 of the snap element 24. In addition, the driver 36 has a protrusion 136, which has a chamfered surface 136a, which engages with the opening 130 of the snap element 24. While the opening 130 and the protrusion 136 form an axial fixing device, the notch 132 and the rib 134 form a rotational fixing device. Due to the axial and rotational fixing device, the snap element 24 and the driver 36 can be connected to each other in a defined relative rotational position. In order to strengthen the rotational fixation between the snap element 24 and the driver 36, an axially extending rib 138 is formed on the inner circumferential surface of the snap element 24 (see Figure 6C ), the rib 138 and the axially extending groove 140 on the outer peripheral surface of the driver 36 (see Fig.13D ) join.
[0228] Figures 8A to 8E The dose selector 28 is depicted. The dose selector 28 comprises an axial fixing device 142 in the form of a circumferentially extending protrusion on the inner circumferential surface of the distal section of the dose selector 28. The dose selector 28 is inserted into the circumferentially extending inlet 144 (see Figure 5B ) and is axially fixed to the dose setting knob 22. In the inlet 144, the dose setting knob 22 forms an axial fixing device 146 in the form of a circumferentially extending protrusion on the outer circumferential surface, which engages with the axial fixing device 142 of the dose selector 28 to form an axial connection that allows relative rotational movement between the dose selector 28 and the dose setting knob 22.
[0229] As in Fig. 8E As best seen in FIG. 1 , a rotational securing device 148 in the form of an axially extending groove is formed on the inner circumferential surface of the dosage selector 28. The rotational securing device 148 is in the form of an axially extending rib formed on the outer circumferential surface of the connector 26 (see FIG. 1 ). Figure 7B ) are engaged. The rotational securing means 148, 150 allow axial movement between the dosage selector 28 and the connector 26. The dosage selector 28 further includes a rotational securing means 152 in the form of an axially extending rib formed on the outer peripheral surface of the dosage selector 26. The rotational securing means 152 engages with a rotational securing means 154 in the form of an axially extending groove formed on the inner peripheral surface of the housing 32 (see Fig. 11CThe rotational fixation means 152, 154 are configured to define a single possible rotational alignment that allows the dosage selector 28 to be inserted into the housing 32. The rotational fixation means 150, 152 allow axial movement between the dosage selector 28 and the housing 32.
[0230] In order to limit the deliverable dose, a dose selector 28 (see Figure 8B ) is formed with a circumferentially extending rib 156 having cutouts 158a, 158b, 158c and 158d. The cutouts 158a, 158b, 158c and 158d are assigned to the respective dose stops 118a, 118b, 118c and 118d. The rib 156 with its cutouts 158a, 158b, 158c and 158d ensures that an injection is only possible when the dose limiting element 116 of the snap element 24 is in an angular position associated with one of the cutouts 158a, 158b, 158c and 158d, i.e. associated with one of the settable doses. If the dose limiting element 116 is not in an angular position associated with one of the cutouts 158a-d, an axial movement of the dose limiting element 116 and therefore of the snap element 24 relative to the dose selector 28 is blocked by the circumferentially extending rib 156. As shown from Figure 8B As can be seen, no cutout is allocated for the preset dose hard stop 126. Thus, when the injection pen 10 is set to a preset dose, starting an injection is prohibited.
[0231] According to an alternative embodiment, the circumferentially extending rib 156 may be arranged to interact with the hard stop 124 instead of the dose limiting element 116. Thus, an injection is only possible when the hard stop 124 of the snap element 24 is in an angular position associated with one of the cutouts 158a, 158b, 158c and 158d, i.e. associated with one of the settable doses.
[0232] Fig. 10A and 10B The knob key 30 is depicted. The knob key 30 is configured to be attached to the outer peripheral surface of the dose selector 28 to prevent the dose setting knob 24 from accidentally moving in the proximal direction 1 relative to the housing 32 when the injection pen 10 in the delivery state falls onto its proximal end. The clip element 30 has a width W1, which corresponds to the width W2 between the proximal edge 160 of the dose setting knob 22 and the distal edge 162 of the housing 32 (see Fig.29A). The knob key 30 is C-shaped and has a retaining protrusion 164, which interacts with the rotation fixing device 152 on the outer peripheral surface of the dosage selector 28 to attach the knob key 30 to the dosage selector 28. The knob key 30 can be removed from the dosage selector 28 by slightly bending the C-shaped knob key 30. In the delivery state, the knob cover 16 extends around the knob key 30 to hold the knob key 30 in place. The knob key 30 can only be removed from the dosage selector 28 after the knob cover 16 is removed.
[0233] The housing 32 is Figures 11A to 11C The housing 32 forms a viewing window 166 for displaying the status of the injection pen 10, in particular the set dose indicated by the dose sleeve 34 through the window 166. The dose sleeve 34 rotates relative to the housing during dose setting and dose delivery, which causes the content displayed through the window 166 to change. At different circumferential positions along the outer circumferential surface of the dose sleeve 34, labels 168a-168d for different settable doses are located (see Fig. 12C and 12D In addition, a preset dose label 168e is positioned on the dose sleeve 34 (see Fig. 12B ), which corresponds to the preset dose, i.e., the amount of drug that would be injected if the injection could start from the preset dose. Fig. 12A and 12B As can be seen, the preset dose label 168e is different from the zero dose label 168f, which is a label indicating that no drug will be injected if the injection is started in this state. When the injection is completed, the zero dose label 168f will be displayed through the window 166. Labels 168a, 168b, 168c and 168d correspond to the settable doses defined by the dose stoppers 118a, 118b, 118c and 118d.
[0234] The dose sleeve 34 is rotationally and axially rigidly coupled to a driver 36 (see Figures 13A-13D ). In order to rotationally couple the dose sleeve 34 to the driver 36, corresponding non-circular outer circumferential surfaces 169a and inner circumferential surfaces 169b are formed on the driver 36 and the dose sleeve 34, respectively. In addition, the dose sleeve 34 forms a fixing section 171, which is clamped between the proximal end of the snap element 24 and the face surface 173 of the driver 36 (see Fig.13A ) between the dose sleeve 34 to axially fix the driver 36 and the snap element 24. The driver 36 forms an external thread 170, which mates with the internal thread 172 of the piston guide 42 (see Figures 16A-16B) are engaged. The threaded connections 170, 172 rotate the driver 36 when the driver 36 moves axially relative to the piston guide 42, and move the driver 36 axially relative to the piston guide 42 when the driver 36 rotates relative to the piston guide 42. In addition, the driver 36 defines an end stop 174, which abuts against an end stop 176 of the piston guide 42 at the end of dose delivery. The surfaces defining the end stops 174, 176 are arranged parallel to the center axis of the injection pen and face in a radial direction. The driver 36 also forms an attachment device 177 in the form of a radially extending hook for attaching one end section of the spring 40 to the driver 36. The other end section of the spring 40 is attached to an attachment device 179 (see Fig. 16C ).
[0235] According to an alternative version, the dose sleeve and the driver may be formed as separate parts which are axially movable relative to each other but rotationally fixed to each other, and both the dose sleeve and the driver may have threads threadedly coupled to the housing. The threads of the dose sleeve and the threads of the driver may have different pitches.
[0236] The piston guide 42 is axially and radially fixed to the housing 32 and can therefore be regarded as a part of the housing. In order to axially fix the piston guide 42 to the housing 32, an axial fixing device 178 in the form of a circumferentially extending groove is formed on the piston guide 42, and the axial fixing device 178 is formed on the inner peripheral surface of the housing 32. The axial fixing device 180 in the form of a circumferentially extending rib (see Fig.11A ) In order to rotationally fix the piston guide 42 to the housing 32, a rotation fixing device 182 in the form of an axially extending groove is formed on the outer peripheral surface 262 of the piston guide 42, and the rotation fixing device 182 is engaged with a rotation fixing device 184 in the form of an axially extending rib formed on the inner peripheral surface of the housing 32 (see Fig.11A The axial and rotational securing means 178, 180, 182 and 184 allow the piston rod guide 42 to be attached to the housing 32 in exactly one relative rotational position.
[0237] The piston guide 42 has a non-circular axial opening 186 (see Fig. 15C ), which is in contrast to the non-circular cross-section 188 of the piston rod 44 (see Fig. 17B ) corresponds to the piston rod 44. Therefore, the piston rod 44 can move axially relative to the piston rod guide 42, but cannot rotate relative to the piston rod guide 42. The piston rod 44 forms an external thread 190, which aligns with the internal thread 192 of the nut 38 (see Fig.14D) are engaged. The outer thread 190 and the inner thread 192 form a threaded connection 189 between the piston rod 44 as a first threaded element and the nut 38 as a second threaded element. The piston rod 44 and the nut 38 can move relative to each other in a combined axial and rotational movement of forced guidance. In the proximal end section of the nut 38, an annular pressing surface 194 extending in the distal direction is formed on the nut 38. During dose delivery, this pressing surface 194 abuts against a front surface 196 of the driver 36. During dose delivery, the driver 36 moves relative to the piston rod guide 42 in a combined axial and rotational movement, while the nut 38 is rotationally fixed to the housing 32. In order to reduce friction during dose delivery, a ball bearing and / or a sliding disk made of a low-friction material can be arranged between the pressing surface 194 and the front surface 196 of the driver 36. In both cases, during dose delivery, the driver 36 pushes the piston rod 44 in the proximal direction 1 via the nut 38.
[0238] The piston rod 44 forms a coupling device 198 in the form of an undercut at its proximal end, which couples with a coupling device 200 in the form of a radially inwardly extending rib on the inner peripheral surface of the piston plate 46 (see Figures 18A-18C ) join.
[0239] Figures 15A to 22B Portions of a drug mixing or reconstitution unit 56 are depicted, which is configured to mix different components, typically a lyophilized drug and a liquid solvent, to form an injectable liquid drug. Figures 19A to 19C In FIG. 4 , a dual chamber cartridge 48 is shown. The dual chamber cartridge 48 is made of a transparent material such as glass. Fig.19C As can be seen, the barrel 48 forms a first chamber 202 and a second chamber 204. Fig.19C In the delivery state shown in , the first chamber 202 arranged proximally of the second chamber 204 includes a bypass 206. The first chamber 202 and the second chamber 204 are separated by a first sealing element 208, which is made of a rubber material, for example, and is axially slidably arranged in the double chamber barrel 48. In other words, the first sealing element 208 forms the distal end of the first chamber 202 and the proximal end of the second chamber 204. The second sealing element 210, for example, made of a rubber material, forms the distal end of the second chamber 204. The second sealing element 210 can also be called a plunger. During the mixing of the two components, the piston disc 46 abuts the distal end face of the second sealing element 210.
[0240] In the delivery state, the lyophilized drug is in the first chamber 202 and the solvent is in the second chamber 204 .
[0241] The dual chamber cartridge 48 is stored in the cartridge key 52 (see Fig.21A-22b). The barrel key 52 is axially and rotationally fixed to the barrel container 50. To achieve this, the barrel key 52 forms an axial fixing device 212 in the form of a circumferentially extending groove, which is in contact with the axial fixing device 214 in the form of a circumferentially extending rib on the inner peripheral surface of the barrel container 50 (see Fig. 20A ) engagement. In addition, the barrel key 52 forms a rotational securing device 216 in the form of a radially extending rib, which engages with a rotational securing device 218 in the form of a radially extending groove on the inner peripheral surface of the barrel container 50. When the barrel key 52 is attached to the barrel container 50, the annular end surface 266 ( Fig. 22B ) and the corresponding annular end surface 268 ( Fig. 20A ) axial abutment (aerial abutment). Both annular end faces 266 and 268 can be arranged perpendicular to the longitudinal axis of the pen 10. In addition, when the barrel key 52 is attached to the barrel container 50, the window 220 formed in the barrel key 52 is aligned with the window 222 in the barrel container 50, so that the patient can see the medicine in the transparent dual-chamber barrel 48 during reconstitution. At the proximal end of the barrel key 52, which also defines the proximal end of the injection pen 10, a thread 224 is formed for attaching a needle (not shown). The thread 224 surrounds an opening 252 at the proximal end of the barrel holder 52. The opening 252 is configured to receive a needle connected to the interior fluid of the barrel 48 inserted into the barrel holder 52.
[0242] The barrel key 52 forms an inner surface 254 ( Fig. 22B ), the inner surface 254 defines a cylindrical socket that receives the barrel 48 and prevents the barrel 48 from tilting relative to the longitudinal axis. Tilting of the barrel 48 is prevented by the area contact between the cylindrical outer surface 256 of the barrel and the inner surface 254 in the retaining section 249 of the barrel holder 52. In addition, the barrel holder 52 forms a cutout 221 to receive the bypass 206 of the dual-chamber barrel 48. The bypass 206 engages the cutout 221 in a form-fitting manner so that the dual-chamber barrel 48 is axially and rotationally fixed to the barrel key 52. On the opposite side of the cutout 221, a notch 223 extending in the axial direction is formed. The notch 223 allows the barrel key 52 to be reversibly widened to axially insert the dual-chamber barrel 48 with the bypass 206.
[0243] To mix the different components in the dual chamber cartridge 48 and prepare the injection pen 10, the cartridge container 50 is screwed onto the piston rod guide 42 until the distal surface 226 of the cartridge container 50 abuts the proximal surface 228 of the piston guide 42 (see Fig. 15BTo do this, the cartridge container 50 forms an outer surface 246 that can be grasped with one hand to rotate the cartridge container 50 onto the piston rod guide 42. When the cartridge container 50 is rotated onto the piston rod guide 42, the proximal portion of the piston rod guide 42 enters the annular space 258 (between the outer peripheral surface 264 of the cartridge holder 52 and the inner peripheral surface 260 of the cartridge container 50) Fig. 23B ), thereby defining the inner space 248 of the cartridge container 260. In order to screw the cartridge container 50 onto the piston rod guide 42, a first thread 230 is formed on the inner circumferential surface 260 of the cartridge container 50, and the first thread 230 is engaged with a second thread 232 formed on the outer circumferential surface 262 of the piston rod guide 42. Fig.15A As can be seen in the figure, the piston rod guide 42 forms a snap element 234. If the snap element 234 is engaged with one of the openings 236, 238 and 240, the snap element 234 allows the cartridge container 50 to rotate relative to the piston rod guide 42 in the distal direction, i.e., a combined axial and rotational movement of the forced guide, but prevents the cartridge container 50 from rotating relative to the piston rod guide 42 in the proximal direction 1. The first opening 236 (see Fig. 20B ) is configured to define the starting position of the cartridge container 50 and ensure that the cartridge container 50 cannot be separated from the piston rod guide 42. Fig.25A and 25B This starting position or delivery state is shown in .
[0244] The second opening 238 defines a reconstituted state of the cartridge container 50. In this state, the second chamber 202 still contains air, allowing the injection pen 10 to move forward and backward to ensure that the drugs are evenly mixed together. The second opening 238 can be omitted. Therefore, the present disclosure also relates to an embodiment of the injection pen 10, which has the first opening 236 and the third opening 240, but does not have the second opening 238. The third opening 240 defines a knob cover unfastened state of the cartridge container 50, wherein most of the air is exhausted from the second chamber 202, which now contains the reconstituted drug ready for use.
[0245] In the following about Figures 23A to 33B , which describes different states of the injection pen 10 during use of the pen 10 .
[0246] FIG. 23A to FIG. 25B The injection pen 10 is depicted in a delivery state. Fig.23A As can be seen in FIG, the knob cover 16 covers the distal end section of the injection pen 10 up to the junction between the housing 32 and the piston guide 42. Thus, the dose setting knob 22 is completely covered by the knob cover 16, making it impossible for the user to set a dose prematurely in this state. Fig. 23BAs can be seen, in the delivery state, the drug reconstitution unit 56 forms two separate chambers 202, 204 separated by the first sealing element 208. This means that the two components of the drug, each stored in one of the two chambers 202, 204, have not yet been mixed together. Fig.24 As can be seen in the figure, the knob cover 16 is eliminated to show the portion below the knob cover 16, and the dose setting sleeve 34 indicates that the injection pen 10 is in a preset state different from the zero dose state. Therefore, the dose setting knob 22 is also in a preset position different from the zero dose position. As shown in Fig.25A and 25B As can be seen in FIG. 4 , the snap element 234 of the piston rod guide 42 snaps into the first opening 236 of the cartridge container 50 . Fig.24 , the cartridge container 50 is depicted as translucent in order to show the first threads 230 formed on the inner circumferential surface of the cartridge container 50. Secondly, the piston rod guide 42 is also depicted as translucent in order to show the position of the piston rod 44 in a preset state.
[0247] To begin preparation of a drug product, such as by comparing Fig.25A and 26A As can be seen, the user rotates the cartridge container 50, which causes the cartridge container 50 including the cartridge key 52 and the dual chamber cartridge 48 to move in the distal direction relative to the piston rod guide 42. As a result, the piston rod guide 42 moves into the annular space 258 ( 258 ) between the cartridge container 50 and the cartridge holder 52. Fig. 23B ). The piston disc 46 is snapped onto the piston rod 44, which is rotationally fixed by the piston rod guide 42 and axially fixed by the nut 38. Therefore, the piston disc 46 prevents the movement of the second sealing element 210 arranged in the dual-chamber barrel 48, so that when the barrel container 50 is further rotated onto the piston rod guide 42, the second sealing element 210 slides along the inner circumferential surface of the dual-chamber barrel 48. The solvent stored in the second chamber 204 pushes the first sealing element 208, which also causes the first sealing element 208 to slide along the inner circumferential surface of the dual-chamber barrel 48. This will cause an overpressure in the barrel, but the air can escape through the double-ended needle attached to the thread 224 by the user. When the first sealing element 208 reaches the bypass 206 (see Fig. 23B ), the first chamber 202 and the second chamber 204 are connected by the bypass 206, and thus, the lyophilized drug stored in the first chamber 202 and the solvent stored in the second chamber 204 are mixed.
[0248] exist Figures 26A to 27C In the reconstituted state shown in FIG, the mixed drug is stored in the first chamber 202 between the first sealing element 208 and the proximal end 14 of the dual chamber cartridge 48. Fig.26BAs can be seen in FIG. 2 , the proximal surface of the second sealing element 210 abuts against the distal surface of the first sealing element 208, so that the second chamber 204 no longer exists in the reconstituted state. Fig.27C As can be seen in the figure, the snap element 234 of the piston rod guide 42 is snapped into the second opening 238 of the cartridge container 50. In this state, the front chamber 202 still contains a lot of air, which helps to create turbulence when moving the pen, making the mixing of the lyophilized drug easier. As mentioned above, the second opening 238 can be omitted. In this case, mixing is performed with a small amount of air remaining.
[0249] After the drug reconstitution is completed, the user further rotates the cartridge container 50, thereby further moving the cartridge container 50 axially in the distal direction relative to the piston rod guide 42. This causes the displacement section 242 located at the distal end of the cartridge container 50 to engage with the wing 58 of the knob cover 16 and extend the wing 58 radially outward (see Fig.28B ). Extending the wings 58 radially outward disengages the form-fitting engagement means 60 of the knob cover 16 from the coupling surface 228, so that the knob cover 16 can move axially relative to the housing 32. The knob cover 16 can now be pulled away from the housing 32 in the distal direction, thereby obtaining Fig.29A and 29B When the cartridge container 50 is completely rotated onto the piston rod guide 42, the radial end stopper 244 formed on the outer peripheral surface 262 of the piston rod guide 42 abuts against the radial end stopper (not shown) on the inner peripheral surface of the cartridge container 50. In addition, the snap element 234 of the piston rod guide 42 snaps into the third opening 240. Therefore, the cartridge container 50 is rotationally locked to the piston rod guide 42 and the housing 32 of the device. Therefore, the movement of the cartridge container 50 and the cartridge 48 relative to the housing 32 and the piston rod guide 42 is prohibited.
[0250] As in Fig.29A and 29B As can be seen in the figure, the knob key 30 is still clamped to the outer peripheral surface of the dose selector 28 between the proximal edge 160 of the dose setting knob 22 and the distal edge 162 of the housing 32. The knob key 30 can only be removed from the dose selector 28 after removing the knob cover 16 by slightly bending the knob key 30.
[0251] Afterwards, if we compare Fig.29A and 30A As can be seen, the user rotates the dose setting knob 22 to set a desired dose among a plurality of possible settable doses. In this example, the dose setting knob 22 is rotated 180° to set the desired dose. When the dose setting knob 22 is rotated, the dose setting knob 22 performs a combined axial and rotational movement, i.e. a helical movement, in a forced-guided manner in the distal direction.
[0252] Rotating the dose setting knob 22 causes rotation of the injection button 18, which is axially and rotationally connected to the dose setting knob 22 by the snap ring 20; the snap element 24, which is rotationally connected to the dose setting knob 22 by the teeth 108 intermeshing with the teeth 110; the driver 36, which is rotationally and axially coupled to the snap element 24; and the dose setting sleeve 34, which is rotationally and axially coupled to the driver 36. Due to the engagement of the outer thread 170 of the driver 36 with the inner thread 172 of the piston rod guide 42, the rotation of the driver 36 causes the driver 36 to move axially in the distal direction. The axial movement of the driver 36 causes the snap element 24 to move in the distal direction, which pushes the injection button 18 and the dose setting knob 22 in the distal direction through the coupling means 102 of the snap element 24 interacting with the assembly means 98 of the injection button 18. This causes the dose setting knob 22 to perform a combined axial and rotational movement of forced guidance during dose setting.
[0253] Furthermore, rotating the dose setting knob 22 causes a rotation of the injection button 18 which is rotationally coupled to the nut 38. Since the piston rod 44 is rotationally fixedly coupled to the piston rod guide 42 due to its corresponding non-circular cross-sections 186, 188, the nut 38 moves in the distal direction when the dose setting knob 22 is rotated and thus the nut 38 is rotated.
[0254] The amount of axial movement of the nut 38 relative to the piston rod 44 and the driver 36 relative to the piston guide 42 depends on the pitch of the respective threads. The external thread 170 of the driver 36 has a larger pitch than the external thread 190 of the piston rod 44, so that the driver 36 moves more in the distal direction than the nut 38. For example, the external thread 170 of the driver 36 may have a pitch of 10.71 mm, and the external thread 190 of the piston rod 44 may have a pitch of 10.21 mm.
[0255] When a desired dose is set, the helical torsion spring 40 applies a torque to the snap element 24 via the driver 36 to bring the dose defining element 116 into abutment with the respective dose stop 118a to 118d, i.e., into abutment with the side surface 122b thereof. Due to the spring 40, the injection pen 10 is configured to rotationally self-align the snap element 24 and the dose selector 28 in different predetermined rotational positions defining a predetermined dose.
[0256] If the user subsequently presses the injection button 18 on the distal end 12 of the injection pen 10, the dose setting knob 22 moves in the proximal direction 1 relative to the catch element 24. This causes the coupling device 100, which bends when passing the circumferential flange 102, to cause a reaction force in the distal direction, which the user needs to overcome in order to start the injection process. The movement of the dose setting knob 22 in the proximal direction 1 relative to the catch element 24 also causes the teeth 108 of the dose setting knob 22 to disengage from the teeth 110 of the catch element 24 and, instead, causes the teeth 108 of the dose setting knob 22 to engage with the teeth 114 of the connector 26. Since the connector 26 is rotationally coupled to the housing 32 via the dose selector 28, the dose setting knob 22 is rotationally fixed to the housing 32. Therefore, during dose delivery, the dose setting knob 22, the injection button 18, the dose selector 28 and the nut 38 do not rotate relative to the housing 32.
[0257] If the user further presses the injection button 18, the injection button 18 and the dose selector 28 move in the proximal direction 1 relative to the snap element 24. Thereby, the dose limiting element 116 of the snap element 24 passes the circumferentially extending rib 156 on the dose selector 28 through the respective cutouts 158a-158d corresponding to the set dose. At the same time, the hard stop 126 of the dose selector 28 moves in the axial direction relative to the hard stop 124 on the snap element 24, which allows the dose selector 28 and the snap element 24 to rotate relative to each other through the preset dose position towards the zero dose position.
[0258] When the injection button 18 is pressed during dose delivery, the injection button 18 pushes the driver 36 in the proximal direction 1 via the snap element 24. The spring 40 supports the axial movement of the driver 36 by applying a torque to the driver 36, thereby causing the driver 36 to move axially in the proximal direction 1 due to the external thread 170 of the driver 36. The driver pushes the nut 38 in the proximal direction 1, which causes the piston rod 44 to move in the proximal direction 1. The movement of the piston rod 44 and the piston disc 46 in the proximal direction 1 causes the drug to be injected into the patient. Since the injection pen 10 is made to inject relatively large amounts of drug, the pen 10 does not have a so-called transmission device. In other words, the part that is configured to rotate relative to the housing during dose delivery is connected to the housing 32. This means that the distance that the piston disc 46 advances is substantially equal to the distance that the injection button 18 is pushed relative to the housing 32 in the proximal direction 1.
[0259] Since the driver rotates relative to the housing due to its external thread 170, the dose setting sleeve 34 rotates during dose delivery. Fig.33A and 33B), the dose setting sleeve 34 is in a rotated position in which the zero dose label is visible through the window 166 of the housing 32. The end-of-dose stop 174 of the driver 36 (see Fig. 13B ) and the end-of-dose stop 176 of the piston rod guide 42 (see Fig. 16C ) defines the end point of the movement of the injection button 18 in the proximal direction 1 during dose delivery.
[0260] At the end of dose delivery, the coupling means 100 on the injection button 18 passes over the coupling means 102 of the snap element 24 when the injection is initiated, which permanently rotationally couples the dose setting knob 22 and the injection button 18 to the housing 32. As a result, the injection pen 10 becomes inoperable as the user cannot rotate the dose setting knob 22 to set a new dose.
[0261] The injection pen 10 allows the axial position of the piston rod 44 to be adjusted relative to the housing 32 in the pre-assembled state of the dose delivery mechanism 54. In the pre-assembled state, the injection button 18 forming the adjustment element 18 of the dose delivery mechanism 54 engages with its distal assembly means 98a with the coupling means 102 of the snap element 24. This allows the injection button 18 to be positioned in a more distal pre-assembly position than its assembly position in the assembled state of the dose delivery mechanism 54, in which the adjustment element 18 engages with its proximal assembly means 98b with the coupling means 102.
[0262] In the pre-assembled position, the adjustment element 18 protrudes from the dose setting element 22 and is free to rotate relative to the dose setting element 22. Rotation of the adjustment element 18 then rotates the nut 38 relative to the piston rod 44 and thereby causes an axial movement of the piston rod 44 due to the threaded connection 189 between the piston rod 44 and the nut 38.
[0263] Adjustment of the piston rod 44 in the pre-assembled state is described in further detail below in conjunction with a second injection pen 330 according to the present disclosure, which is a variation of the injection pen 10 shown in the previous figures.
[0264] Fig.34 and Fig.35 The second injection pen 300 is shown in a pre-assembled state. Fig.36 shows an exploded view of a second injection pen, and Fig.37 A longitudinal section of the second injection pen 300 is shown in a pre-assembled state. The second injection pen 300 is constructed as disclosed for the injection pen 10 of the previous figures, and vice versa, as long as differences are not disclosed in the description or the figures.
[0265] The second injection pen 300 comprises a dose delivery mechanism 354. The dose delivery mechanism 354 of the second injection pen 300 is constructed as disclosed for the dose delivery mechanism 54 of the injection pen 10, and vice versa, as long as differences are not disclosed in the description or drawings.
[0266] The dose delivery mechanism 354 comprises a housing 332 having an upper housing part 333 and a piston rod guide 342 forming a lower housing part. The upper housing part 333 and the piston rod guide 342 are rigidly connected to each other by a form-fit connection. In particular, the upper housing part 333 and the piston rod guide 342 are axially and rotationally fixed to each other. The lower housing part formed by the piston rod guide 342 is configured to be connected to a medicament container holder 305 receiving a medicament container 348. The medicament container holder 305 comprises a connector 307 at a distal end of the medicament container holder 305. The connector 307 is configured to be connected to a corresponding connector 343 of the piston rod guide 342, which is accessible at the proximal side of the piston rod guide 342. After the medicament container holder 305 is attached to the housing 332, the connectors 307, 343 provide a non-releasable form-fit connection between the medicament container holder 305 and the housing 332.
[0267] The drug container 348 has a single drug chamber which is sealed at its distal end by a single plunger 210 (see Fig.35 ). The drug chamber contains a fluid drug. At its proximal needle end 349, the drug container 348 includes a septum that is configured to be pierced when the double-sided cannula is attached to the needle connector 306 located at the proximal end of the drug container holder 305. During storage of the injection pen 300, the cap 301 can be releasably attached to the drug container holder 305.
[0268] The dose delivery mechanism 354 comprises an injection button constituting the adjustment member 318, a snap element 24, a dosing element 334 and a driver 336. In the pre-assembled state and the assembled state of the injection pen 300, the snap element 24 and the dosing element 334 are rigidly connected to each other and form a dosing member 323 of the dose delivery mechanism 354. The dosing element 334 is coupled to the housing 332 of the dose delivery mechanism 354 via a threaded connection 335. The threaded connection 335 comprises an external thread on the outer surface of the dosing member 323 and an internal thread on the inner surface of the housing 332 ( Fig.36 For other embodiments, the quantitative supply member 323 may also be constructed as a single component.
[0269] The dosing member 323 constitutes a dose indicating member of the dose delivery mechanism 354. Thus, the dosing element 334 comprises markings which are visible through a window in the upper housing part 333 of the housing 332 when the dosing element 323 rotates relative to the housing 332 during dose setting.
[0270] The driver 336 is connected to the housing 332 by another threaded connection 337, which acts between the driver 336 and the piston rod guide 342, as described for the driver 36 and the piston rod guide 42 of the injection pen 10. In addition, the driver 336 is rotationally fixed and axially movable relative to the dosing member 323 by a spline connection. Thus, the driver 336 is received in the dosing element 334 of the dosing member 323. The spline connection includes a first spline element on the outer periphery of the driver 336, which engages with a corresponding second spline element on the inner periphery of the dosing element 334. The simultaneous rotation of the driver 336 and the dosing member 323 requires an axial movement of the driver 336 due to the other threaded connection 337 with the housing 332, and requires a simultaneous axial movement of the dosing member 323 due to the threaded connection 335 with the housing 332.
[0271] The pitch of the threaded connection 335 between the dosing member 334 and the housing 332 is different from the pitch of another threaded connection 337 between the driver 336 and the housing 332. The ratio of these pitches defines the mechanical advantage of the dose delivery mechanism 354 during dose delivery, and the forced proximal movement of the dosing member 334 by a first axial distance causes the driver 336 to move proximally by a second axial distance that deviates from the first axial distance.
[0272] Fig.38 A detailed view of the distal part of the second injection pen 300 in a pre-assembled state is shown. The adjustment element 318 differs from the adjustment element 18 of the injection pen 10 in that it does not have a coupling device 100 to axially lock the adjustment element 18 to the snap element 24 when a dose is delivered. Therefore, the second injection pen 300 allows repeated setting and injection of user-definable doses. Apart from this modification, the adjustment element 318 is constructed as disclosed for the adjustment element 18, and vice versa. In particular, the adjustment element 18 of the injection pen 10 is configured to adjust the position of the piston rod 46 in the pre-assembled state in the same manner as disclosed below for the adjustment element 318 of the second injection pen 300. Furthermore, the adjustment element 318 forms an actuation member of the second injection pen 300. The actuation member is configured to be activated by a user to deliver a set dose. Exemplarily, the actuation member is configured to be pushed by a user in the proximal direction to deliver a set dose.
[0273] exist Fig.37 and38 In the pre-assembled state shown in , the proximal assembly means 98b of the adjustment element 318 engages with the coupling means 102 of the snap element 24 to allow the adjustment element 318 to be positioned in a pre-assembly position relative to the housing 332. The pre-assembly position is the most distal axial position of the adjustment element 318 reached when the assembly means 98b engages with the coupling means 102 of the snap element 24 upon distal movement of the adjustment element 318. The biasing element 250 is in the form of a spring, which acts between the snap element 24 and the adjustment element 318, which biases the adjustment element 318 in the distal direction to the pre-assembly position. Since the injection pen 10 does not have the biasing element 250, the adjustment element 18 of the injection pen 10 is not maintained in the pre-assembly position. For the injection pen 10, the assembler of the device manually positions the adjustment element 18 in the pre-assembly position.
[0274] The assembly device 98b forms the locking part of the locking mechanism 99, and the coupling device 102 of the snap element 24 forms the locking counterpart of the locking mechanism 99. In addition, the dosing member 323 with the snap element 24 forms the counterpart of the locking mechanism 99. The locking mechanism 99 prevents the adjustment element 318 from being disengaged from the housing 332 in the preassembled state.
[0275] In the pre-assembled position, the adjustment element 318 protrudes distally from the dose setting element formed by the dose knob 22. The rotational securing means 90 of the adjustment element 318 then does not engage the rotational securing means 94 of the snap ring 20, so that the adjustment element 318 is rotationally movable relative to the housing 332 and the dose setting element 22.
[0276] In the pre-assembly position, the assembler of the injection pen 300 has access to the outer edge 19 of the adjustment element 318. When the adjustment element 318 is rotated relative to the housing 332 and the dose setting element 22, the adjustment element 318 rotates the nut 38. The nut 38 thus cannot move axially relative to the housing 332, because it is limited by the fixed driver 336 pushing against the pressing surface 194 at the proximal end of the nut 38. Then, the threaded connection 189 between the piston rod 44, which forms the first threaded element, and the rotating nut 38, which forms the second threaded element, enables the piston rod 44 to move axially relative to the housing 332. Thus, the second injection pen 300 allows the axial position of the piston rod 44 to be adjusted by rotating the adjustment element 318 relative to the housing 332 and the dose setting element 22. The same applies to the injection pen 10, whose injection button 18 also forms an adjustment element.
[0277] The dose delivery mechanisms 54, 354 of the injection pens 10, 300 each comprise a rotation lock 89, which is formed by a rotational fixation 90 of the respective adjustment element 18, 318 and a toothed portion 93 of the respective snap ring 20. Thereby, the snap ring 20 forms a connector between the respective adjustment element 18, 318 and the respective dose setting element 22, and the adjustment element 18, 318 is rotationally and / or axially fixed to the dose setting element 22 in the assembled state by means of the connector 20. Furthermore, the dose setting element 22 forms a counter element to which the adjustment element 18, 318 is attached in the assembled state of the respective dose delivery mechanism 54, 354.
[0278] Furthermore, the axial fixing means 82 of the setting element 18, 318 and the rib 84 of the snap ring 20 each form an axial lock 81 which allows an axial movement between the setting element 18, 318 and the dose setting element 22 in a pre-assembled state of the dose delivery mechanism 54, 354 and prevents an axial movement between the setting element 18, 318 and the dose setting element 22 in an assembled state.
[0279] The axial fixing means 82 of the setting element 18, 318 and the ribs 84 of the snap ring 20 also form a locking mechanism, which acts between the setting element 18, 318 and the counter-element formed by the dose setting element 22. In the assembled state of the dose delivery mechanism 54, 354, the locking mechanism prevents the setting element 18, 318 from moving from a second position relative to the counter-element to a first position relative to the counter-element. Thereby, the second position is a proximal position, in which the setting element 18, 318 is rotationally and axially fixed to the counter-element, and the first position is a distal position, which the setting element 18, 318 occupies in the pre-assembled state and in which the setting element 18, 318 can rotate relative to the counter-element.
[0280] Fig.39 shows a detailed view in longitudinal section of the distal end of the second injection pen 300 in an assembled state during dose setting, and Fig.40 Another longitudinally cut detailed view of the distal end of the second injection pen 300 is shown in an assembled state during dose setting. Fig.39 and 40 The section planes of the longitudinal sections shown in FIG. 5 are oriented perpendicular to one another.
[0281] The injection pen 300 is transformed from the pre-assembled state into the assembled state by moving the adjustment element 318 proximally from the pre-assembly position to the assembled position relative to the dose setting element 22 and the housing 332. This rotationally and axially locks the adjustment element 318 to the dose setting element 22 via the connector 20, the rotation lock 89 and the axial lock 81. In the assembled state, the distal assembly means 98a of the adjustment element 318 engage with the coupling means 102 of the snap element 24, thereby irreversibly preventing the adjustment element 318 from moving from the assembled position to the pre-assembly position.
[0282] The distal assembly means 98a of the adjustment element 318 forms a locking portion of the locking mechanism 97, which is configured to prevent the adjustment element 318 from moving from the assembly position to the pre-assembly position relative to the housing 332. The coupling means 102 of the snap element 24 forms a locking counterpart of the locking mechanism 97, and the dosing member 323 with the snap element 24 forms a counterpart of the locking mechanism 97.
[0283] Fig.41 shows a detailed view in longitudinal section of the distal end of the second injection pen 300 in an assembled state during dose delivery, and Fig.42 Another longitudinally cut detailed view of the distal end of the second injection pen 300 is shown in an assembled state during dose delivery. Fig.41 and 42 The section planes of the longitudinal sections shown in FIG. 5 are oriented perpendicular to one another. Fig.41 and 42 The injection pen 300 is thereby shown at the end of dose delivery, when the set dose has been completely expelled and the adjustment element 318 is still pressed in the proximal direction 1 by the user of the injection pen 300 .
[0284] During dose setting in the assembled state, the adjustment element 318 is rotationally coupled to the dosing member 323 via a clutch mechanism 107 formed by teeth 108 on the inner surface of the dose setting element 22 (see FIG. 5 ) and teeth 110 on the outer surface of the snap element 24 (see FIG. 6 ). The dose setting element 22 forms a first clutch member of the clutch mechanism 107 and the snap element 24 forms a second clutch member of the clutch mechanism 107. The dosing members 23, 323 of the dose delivery mechanism 54, 354 each form a respective further member of the dose delivery mechanism 54, 354.
[0285] With each dose delivery mechanism 54, 354, during dose setting in the assembled state, the corresponding clutch mechanism 107 rotationally couples the corresponding adjustment element 18, 318 to the corresponding other component in the closed state of the corresponding clutch mechanism 107, and during dose delivery in the assembled state, the corresponding adjustment element 18, 318 is rotationally separated from the corresponding other component in the open state of the corresponding clutch mechanism 107.
[0286] For other embodiments of the clutch mechanism 107 that couples the adjustment element 18, 318 to another component, the second clutch component can also be formed integrally with the other component. For example, when the snap element 24 and the dosing element 334 are integrally formed into a one-piece dosing component 323, the dosing component 323 constitutes the other component and simultaneously constitutes the second clutch component.
[0287] During dose delivery, the clutch mechanism 107 is disconnected, thereby rotationally decoupling the adjustment element 318 and the dosing member 323. In the pre-assembled state, the clutch mechanism 107 is closed, but the adjustment element 318 is rotationally decoupled from the clutch mechanism 107, so that the clutch mechanism 107 does not transfer the rotation of the adjustment element 318 to the dosing member 323. In particular, the adjustment element 318 is rotationally decoupled from both the dose setting element 22 and the dosing member 323 in the pre-assembled state.
[0288] During dose delivery in the assembled state, the adjustment element 318 is rotationally coupled to the housing 332 via a further clutch mechanism 113, whereby the further clutch mechanism 113 is formed by teeth 108 on the inner surface of the dose setting element 22 and teeth 114 on the outer surface of the connector 26. Thereby, the dose setting element 22 forms a first clutch member of the further clutch mechanism 113 and the connector 26 forms a second clutch member of the further clutch mechanism 113. If the further clutch mechanism 113 is in the closed state and the first clutch member is engaged with the second clutch member, the adjustment element 318 is rotationally fixed to the additional member, which is formed by the housing 332.
[0289] During dose setting, the further clutch mechanism 113 is opened so that the adjustment element 318 is allowed to rotate relative to the housing 332. During dose delivery, the further clutch mechanism 118 is closed so that the adjustment element is rotationally fixed relative to the housing. In the pre-assembled state, the adjustment element 318 is rotationally decoupled from the further clutch mechanism 113, as it is allowed to rotate relative to both the first clutch member formed by the dose setting element 22 and the second clutch member formed by the connector 26.
[0290] Fig.43A longitudinal section through the dose setting element 22 of the injection pen 10 and the second injection pen 300 is shown, Fig.44 shows a perspective view of a longitudinal section of the dose setting element 22, Fig.45 A distal perspective view of the dose setting element 22 is shown, and Fig.46 A proximal perspective view of the dose setting member 22 with the teeth 108 of the clutch mechanism 107 , 113 is shown.
[0291] For both the clutch mechanism 107 and the further clutch mechanism 113, the clutch mechanisms 107, 113 are in a closed state during one of dose setting and dose delivery, and the clutch mechanisms 107, 113 are in an open state during the other of dose setting and dose delivery. Thus, the clutch mechanism 107 is closed when the further clutch mechanism 113 is open, and the clutch mechanism 107 is open when the further clutch mechanism 113 is closed.
[0292] Furthermore, for each clutch mechanism 107, 113, the adjustment element 318 occupies a dose setting position relative to the respective second clutch member 24, 26 during dose setting, and it occupies a dose delivery position relative to the respective second clutch member 24, 26 during dose delivery. Thereby, the dose delivery position is axially moved relative to the dose setting position. Exemplarily, the dose delivery position is axially moved in the proximal direction 1.
[0293] For the dose delivery mechanism 54 , 354 , the further clutch mechanism 113 also forms a locking mechanism which is configured to rotationally lock the adjustment element 18 , 318 to the housing 32 , 332 during dose delivery in the assembled state.
[0294] The dose selectors 28 of the dose delivery mechanisms 54, 354 each form a retaining member of the respective dose delivery mechanism 54, 354. Each adjustment element 18, 318 is located in a first axial position relative to the retaining member in the pre-assembled state, and each adjustment element 18, 318 is transferred from the first axial position to a second axial position relative to the retaining member, thereby transforming the respective dose delivery mechanism 54, 354 from the pre-assembled state to the assembled state. Each adjustment element 18, 318 is rotatable relative to the retaining member in the pre-assembled state.
[0295] During dose setting in the assembled state, each adjustment element 18, 318 is rotatable relative to the respective retaining member, and during dose delivery in the assembled state, each adjustment element 18, 318 is rotationally fixed relative to the respective retaining member. For the dose delivery mechanism 54, 354, each adjustment element 18, 318 is axially fixed relative to the respective retaining member in the assembled state.
[0296] For the dose delivery mechanism 54, 354, during dose setting in the assembled state, the first threaded element formed by the piston rod 44 is axially stationary relative to a third element of the dose delivery mechanism 54, 354. The third element is thereby the housing 32, 332. Furthermore, during dose setting in the assembled state, the second threaded element formed by the nut 38 is axially moved relative to the third element. Upon adjustment of the piston rod 44 in the pre-assembled state, the first threaded element formed by the piston rod 44 is axially moved relative to the third element formed by the housing 32, 332, and the second threaded element formed by the nut 38 is axially stationary relative to the third element formed by the housing 302, 332.
[0297] The dose limiting mechanism 115 acting between the snap element 24 and the dose selector 28 of the dose delivery mechanism 54 , 354 is inactive in the pre-assembled state because the setting element 318 is rotationally decoupled from the snap element 24 , so that the snap element 24 does not rotate when the setting element 318 rotates.
[0298] For both dose delivery mechanisms 54, 354, the adjustment element 18, 318 is configured to rotate in a pre-assembled state until the bearing 46 contacts the distal surface of the plunger 210 after the drug container 48, 348 is attached. The method for adjusting the position of the piston rod 44 in the pre-assembled state of the dose delivery mechanism 54, 354 may include the following steps: attaching the drug container 48, 348 to the housing 32, 332; and rotating the adjustment element 18, 318 until the bearing 46 contacts the distal surface of the plunger 210. Then, the adjustment element 18, 318 may be further rotated until a predetermined torque is required for rotation. Then, the dose delivery mechanism 54, 354 may be transformed from the pre-assembled state to the assembled state.
[0299] The adjustment element 18, 380 may also be rotated until the bearing 46 is located at a distance greater than zero from the distal surface of the plunger 210, thereby forming a gap between the distal surface of the plunger 210 and the proximal surface of the bearing 46. For example, the distance may be measured by measuring the position of the bearing 46 relative to the plunger 210 through the drug container 305, which may be made of a transparent material.
[0300] Alternatively, the method may further comprise the step of adjusting the position of the piston rod 44 by rotating the adjustment element 18, 318 without the drug container 48, 348 being attached to the housing 32, 332. The method may then comprise the step of placing the dose delivery mechanism 54, 354 in a pre-assembled state in an assembly fixture and rotating the adjustment element 18, 318 until the proximal surface of the bearing 46 contacts a reference surface provided by the assembly fixture. Thereby, the reference surface may be located within the proximal cylindrical portion of the connector 43 of the injection pen 10.
[0301] For example, for the injection pen 300, the drug container 348 may be attached to the housing 332, and then the adjustment element 318 may be rotated until the bearing 46 contacts the distal surface of the plunger 210. The adjustment element 318 may then be further rotated until a predetermined torque is required for rotation.
[0302] For the dose delivery mechanism 54 of the injection pen 10, the proximal portion of the piston rod guide 42 forms a connector 43, which is configured to connect an axially movable drug container 48 to the housing 32, so that the drug container 48 can perform an axial movement from a receiving position to an operating position after being connected to the housing 32. Thereby, the receiving position is defined by a snap element 234 of the connector 43 engaging with a distal opening 236 of the drug container holder 50, 52. The operating position is defined by the snap element 234 engaging with a proximal opening 240 of the drug container holder 50, 52 after the drug container holder 50, 52 is screwed onto the connector 43.
[0303] For the injection pen 10, the dose delivery mechanism 54 can be provided without attaching the drug container holder 50, 52 to the housing 32, and the position of the piston rod 44 can be adjusted by rotating the adjustment element 18 before attaching the drug container holder 50, 52 to the housing 32. For example, the dose delivery mechanism 54 can be placed in an assembly jig. Then, the adjustment element 18 can be rotated until the bearing 46 contacts the reference surface of the assembly jig and the bearing 46 and the piston rod 44 have reached a predetermined position relative to the housing 32.
[0304] Thus, the piston rod 44 is adjusted to a position relative to the housing 32 that ensures that the bearing 46 is in contact with the plunger 210 during the movement of the drug container 48 from the receiving position to the operating position. In addition, the position of the piston rod 44 is adjusted to ensure that a certain amount of liquid drug is discharged from the drug container 48 at the end of the movement to the operating position. For example, the position can be adjusted so that the amount of drug is discharged only during the last quarter of a rotation of the drug container holder 50, 52 onto the proximal portion of the piston rod guide 42.
[0305] For both the first injection pen 10 and the second injection pen 300, the piston rod 44 may advance a first distance in the proximal direction 1 when the actuation member 18 moves proximally a second distance, wherein the second distance is less than 1.5 times the first distance. For the first injection pen 10, the first distance is equal to the second distance. Furthermore, when the piston rod 44 travels the first distance, the actuation member 18 travels the second distance. For the second injection pen 300, the ratio between the second distance and the first distance is given by the ratio of the pitch of the threaded connection 335 between the dosing member 323 and the pitch of another threaded connection 337 between the driver 336 and the housing 332.
[0306] Alternative embodiments of the second injection pen 300 may also include a single threaded connection between all components of the second injection pen 300 that rotate during dose delivery and the housing 332. Such alternative embodiments may include the dosing member 23 of the first injection pen 10. As with the first injection pen 10, the dosing member 23 may include Figure 1 The drive 36 , the dosing element 34 and the snap-in element 24 are shown in FIG.
[0307] Additionally or alternatively, the second injection pen 300 may further include the drug reconstitution unit 56 of the first injection pen 10. Thus, such a second injection pen 300 may be configured to receive the dual-chamber cartridge 48 and perform reconstitution of the lyophilized drug prior to drug delivery.
[0308] Additionally or alternatively, the second injection pen 300 may also be configured to permanently axially lock an actuation member, such as an actuation member formed by the adjustment element 318, and / or the dose setting element 22 to the dosing member 323 upon dose delivery. The second injection pen 300 may then comprise the coupling device 100 described in conjunction with the first injection pen 10.
[0309] In general, the first injection pen 10 and the second injection pen 300 may each comprise a blocking mechanism configured to prevent setting and / or delivering a second dose after a first dose has been delivered with the respective injection pen 10, 300. The blocking mechanism may be configured to permanently fix the dose setting element 22 at least rotationally to the housing 32, 332 when a dose is delivered, e.g. when a first set dose is delivered. Additionally or alternatively, the blocking mechanism may be configured to permanently fix the actuation member 18 axially to the counterpart member, whereby the actuation member 18 moves relative to the counterpart member to initiate delivery of the set dose. For the injection pen 10, 300, the respective counterpart member is exemplarily formed by the dosing member 23, 323.
[0310] The blocking mechanism may include a first blocking portion that engages a second blocking portion to prevent setting and / or delivering the second dose. For the first and second injection pens 10 , 300 , the first blocking portion is exemplarily formed by the coupling device 100 and the second blocking portion is exemplarily formed by the coupling device 102 .
[0311] The injection pen 10, 300 may comprise a clutch mechanism which rotationally locks the dose setting member 22 to the housing in a closed state of the clutch mechanism during dose delivery. By locking the clutch mechanism in a closed state, the blocking mechanism may permanently fix the dose setting member 22 at least rotationally to the housing 32, 332. The clutch mechanism may, for example, be the clutch mechanism 107.
[0312] For example, the clutch mechanism may include a first clutch part (e.g., teeth 114 of the connector 26) that engages with a second clutch part (e.g., teeth 108 of the dose setting element 22) in a closed state of the clutch mechanism and disengages from the second clutch part in an open state of the clutch mechanism. For example, the first and second clutch parts may engage and disengage with each other upon axial relative movement relative to each other. For example, the clutch mechanism may be locked in a closed state by axially locking the first clutch part to the second clutch part.
[0313] Similar to the first injection pen 10, embodiments of the second injection pen 300 can be configured to prevent a user from prematurely activating the second injection pen 300. Similar to the first injection pen 10, embodiments of the second injection pen 300 can be configured to axially lock the actuation member 318 relative to the housing 332 before setting and delivering the first dose. Similar to the first injection pen 10, the second injection pen 300 can include a knob cover 16 and / or a knob key 30.
[0314] Similar to the first injection pen 10, the second injection pen 300 can also be preset to an injectable dose higher than zero in the delivery state. For example, the dosing member 323 can be preset to a position corresponding to a set dose higher than zero. Similar to the first injection pen 10, the second injection pen 300 can be configured to prevent the preset injectable dose from being reduced to zero.
[0315] For both the first and second injection pens 10, 300, the dosing member 23, 323 stops rotating in the rotational direction at a first angular position during dose setting, and stops rotating in the rotational direction at a second angular position during dose delivery, whereby the second angular position is spaced apart from the first angular position in the rotational direction by a distance corresponding to a preset dose higher than zero. For example, the dosing member 23, 323 may be in the second angular position at the end of dose delivery.
[0316] The first and second injection pens 10, 300 may include: a first stopper that limits rotation in a rotational direction at a first angular position during dose setting; and / or a second stopper that limits rotation in a rotational direction at a second angular position during dose delivery, for example at the end of dose delivery. For example, the first stopper may be Fig. 9 The stopper 126 shown in FIG. 1 and / or the second stopper may be, for example, Fig. 13B and 15D The end stops 174, 176 shown in FIG.
[0317] For alternative embodiments, a stopper that prevents the dosing member 23, 323 from rotating at the end of dose delivery may also be provided at the corresponding dose selector 28. For example, the stopper may interact with a corresponding stopper (e.g., a hard stopper 124) provided at the dosing member 23, 323. Such a stopper is disclosed in document WO 2020015980 A1, the disclosure of which is incorporated by reference in its entirety into the present disclosure, including the construction of the stopper, which is referred to as a zero dose hard stopper in document WO 2020015980 A1.
[0318] Fig.47 shows a perspective view of a third injection pen 500 according to the present disclosure, Fig.48 An exploded view of a third injection pen 500 is shown, and Fig.49 A longitudinal cutaway view of the dose delivery mechanism 554 of the third injection pen 500 is shown in an assembled state during dose setting. The third injection pen 500 is constructed as disclosed for the second injection pen 300 and vice versa, as long as differences are not disclosed in the description or drawings.
[0319] The dose delivery mechanism 554 comprises a housing 532 which is configured to be connected to the medicament container holder 505 via a non-releasable form-fit connection. The connection comprises a connector 506 at the distal end of the medicament container holder 505. The connector 506 is configured to engage with a corresponding connector 543 at the proximal end of the housing 532, see Fig.49 The connection is designed as a non-releasable snap-on connection.
[0320] The drug container holder 505 is configured to receive the drug container 348 already described in conjunction with the second injection pen 300. At the proximal end, the drug container holder 505 includes a needle connector 306, which is configured to receive a double-ended needle assembly 501 having a double-ended cannula 502. The needle connector 300 is connected to the needle assembly 501 by a threaded connection. Alternatively, the connection may also be configured as a Luer lock, a snap connection, etc. When the needle assembly 501 is mounted on the drug container holder 505, the distal end of the cannula 502 pierces the septum at the proximal needle end 349 of the drug container 348. The proximal end of the cannula 502 is covered by a needle cap 503, which is removed before use of the injection pen 500. During storage of the injection pen 500, the cap 504 covers the drug container holder 505.
[0321] The dose delivery mechanism 554 comprises a dosing member 523 which is axially fixed and rotationally movable relative to the housing 532 by a rotatable fixture 560 . Fig.50 A distal perspective view of the dosing member 523 is depicted, and Fig.51A longitudinal cutaway view of the dosing member 523 is depicted. The rotatable fixture 560 comprises an annular rim 561 at the proximal end of the dosing member 523 and a corresponding retaining lug 533 at the proximal end of the housing 532. The retaining lug 533 snaps behind the annular rim 561 and thus axially secures the dosing member 523 to the housing 532.
[0322] The dose delivery mechanism 554 also includes a piston rod 44, which is Fig.52 567 at the proximal end of the dosing member 523. Thus, the piston rod 44 is connected to the dosing member 523 via a threaded connection 189. The threaded connection 189 comprises an internal thread in the opening 567 of the dosing member 523 and an external thread arranged at the outer periphery of the piston rod 44. The piston rod 44 forms a first threaded element of the threaded connection 189, and the dosing member 523 forms a second threaded element of the threaded connection 189. At its proximal end, the piston rod 44 comprises a coupling device 198, which connects an axially fixed and rotationally movable bearing 46 to the piston rod 44.
[0323] Fig.53 depicts a distal perspective view of the extension 525 of the dose delivery mechanism 554, Fig.54 A distal view of extension 525 is depicted, and Fig.55 A proximal view of the extension 525 is depicted. The extension 525 is received in the dosing member 523. It is held axially fixed and rotatably movable in the dosing member 523 by a rotatable fixture 570. The rotatable fixture 570 illustratively comprises an annular ridge 571 at the proximal end of the extension 525 and a corresponding lug 566 disposed at the proximal end of the dosing member 523. The lug 566 snaps into place behind the annular ridge 571 from the proximal side of the extension 525 and thereby axially fixes the extension 525 to the dosing member 523.
[0324] The piston rod 44 is axially movable but rotationally fixed relative to the extension 525. At its proximal end, the extension comprises a non-circular opening 573, which is adapted to the corresponding non-circular outer shape of the piston rod 44. The piston rod 44 is received in the opening 573, thereby rotationally locking the piston rod 44 to the extension 525 while allowing relative axial movement between the piston rod 44 and the extension 525.
[0325] Fig.56 Depicted is a perspective view of a coupling element 520 of a dose delivery mechanism 554. The coupling element 520 comprises an end plate 580 at its distal end and two rods 582 extending axially in a proximal direction and parallel to each other.
[0326] The coupling element 520 is rotationally fixed and axially movable relative to the piston rod 44. Thus, it is coupled to the piston rod 44 via the extension 525. Fig.57 As can be seen, the rod 582 of the coupling element 520 is received between two ridges 575 of the extension 525, which extend radially from the inner surface of the extension 525. Thus, the ridges 575 extend parallel to each other in the axial direction. The rod 582 and the ridges 575 provide an axially movable connection between the coupling element 520 and the extension 525, which fixes the coupling element 520 to the extension 525 in rotation.
[0327] As from Fig.57 It can further be seen that the adjustment element 518 is axially and rotationally fixed to the distal end of the coupling element 520. Fig.58 depicts a proximal perspective view of the adjustment element 518, Fig.59 depicts a side view of the adjustment element 518, Fig.60 Depicted along Fig.59 A radial cross-section of the adjustment element 518 along line AA in FIG. 1 , and Fig.61 Depicted along Fig.59 0048 is a radial cross-section of the adjustment element 518 along line BB in FIG.
[0328] The adjustment element 518 is axially and rotationally fixed to the coupling element 520. Thus, the adjustment element 518 and the coupling element 520 form a single component of the dose delivery mechanism 554. Fig.56 As can be seen, the coupling element 520 comprises an axial fixing element 584, which is part of an axial fixing member acting between the adjustment element 518 and the coupling element 520 and engages with a corresponding axial fixing element provided at the adjustment element 518. Thus, the axial fixing element 584 of the coupling element 520 is configured as a snap hook, and the corresponding axial fixing element of the adjustment element 518 is configured as a circumferential edge engaging with the snap hook. The coupling element 520 also comprises at least one rotation fixing element 585, for example a plurality of rotation fixing elements 585. The rotation fixing element 585 engages with a corresponding rotation fixing element provided at the adjustment element 518 and thereby rotationally locks the adjustment element 518 to the coupling element 520. The rotation fixing element 585 of the coupling element 520 is configured as a longitudinal ridge extending parallel to the axial direction. These ridges are received between corresponding longitudinal recesses 586 provided in the adjustment element 518. For other embodiments of the dose delivery mechanism 554, the adjustment element 518 and the coupling element 520 can also be configured as a single component of a single piece.
[0329] Fig.62 A perspective view of the coupling member 524 of the dose delivery mechanism 554 is depicted. The coupling member 524 is configured as a hollow member. Fig.49As can be seen, the coupling member 524 is located between the dosing member 523 and the extension 525. Thus, the coupling member 524 is placed within the dosing member 523 and receives the extension 525 in the inner cavity. The coupling member 524 is rotationally fixed to the dosing member 523 by an axially movable rotational fixture 563. The rotational fixture 563 includes a longitudinal recess 590 provided on the outer surface of the coupling member 524, which engages a corresponding longitudinal ridge 564 provided on the inner surface of the dosing member 523, see Fig.50 and 51 .
[0330] Fig.63 A distal perspective view of the sleeve 528 of the dose delivery mechanism 554 is depicted, and Fig.64 A longitudinal cross-sectional view of the sleeve 528 is depicted. The sleeve 528 is constructed as a hollow member. Fig.49 As can be seen, the sleeve 528 is located between the housing 532 and the dosing member 523 .
[0331] The sleeve 528 is threadedly connected and threadedly engaged with the dosing member 523. The threaded connection between the sleeve 528 and the dosing member 523 includes an internal thread 612 provided on the inner surface of the sleeve 528, which engages an external thread 562 provided on the outer surface of the dosing member 523.
[0332] In addition, sleeve 528 is connected to housing 532 in a rotationally fixed and axially movably manner. The connection between sleeve 528 and housing 532 thus includes a connector 620. Connector 620 is located at the distal end of housing 532. It is axially and rotationally fixed relative to housing 532. For other embodiments, connector 620 may also be formed integrally with housing 532. Connector 620 includes a pair of radial lugs 622, which are arranged at the outer surface of connector 620. The radial lugs 622 engage with corresponding openings 535 that are accessible at the inner surface of housing 532. Connector 620 also includes an outer annular rim 626 arranged at the distal end of connector 620. The annular rim 626 rests against the distal surface of housing 532, thereby preventing connector 620 from moving in the proximal direction.
[0333] On the inner surface of the connector 620, longitudinal recesses 624 are provided which engage with corresponding longitudinal ridges 616 on the outer surface of the sleeve 528. This provides a rotationally fixed and axially movable connection between the housing 532 and the sleeve 528.
[0334] The dose sleeve 523 is configured as a dose indicating member and includes markings on its outer surface for indicating a set dose. A window 610 is formed in the sleeve 528 through which the dose sleeve 523 can be seen. The window 610 of the sleeve 528 is aligned with a housing window 534 provided in the housing 532 so that the dose sleeve 523 is visible from the outside of the housing 532. The set dose is then indicated by means of the markings visible through the windows 534, 610.
[0335] The coupling member 524 is axially fixed and rotationally movable relative to the sleeve 528. The connection between the coupling member 524 and the sleeve 528 includes a connector 527.
[0336] Fig.66 depicts a perspective view of connector 527, and Fig.67 A perspective view of a longitudinal section of the connector 527 is depicted. The connector 527 is axially and rotationally fixed relative to the sleeve 528. It includes longitudinal ridges 632 on its outer surface that align with corresponding recesses 618 provided on the inner surface of the sleeve 528 (see Fig.64 ) engagement. In addition, the connector 527 includes radially extending lugs 630 that engage with openings 614 accessible on the inner surface of the sleeve 528. This engagement prevents the connector 527 from being removed from the sleeve 528.
[0337] A distal blocking element 635 and a proximal blocking element 654 are formed on the inner surface of the connector 527. The blocking elements 635 and 654 provide an axially fixed and rotationally movable connection for the coupling member 524. Thus, an annular edge 592 (see FIG. 5A ) disposed on the outer surface of the coupling member 524 and extending in the radial direction is Fig.62 ) is received between blocking elements 635, 654.
[0338] In addition, a radial stopper 568 is formed between the sleeve 528 and the dosing member 523. The radial stopper 568 is configured to stop the relative rotation between the dosing member 523 and the sleeve 528 at the end of the dose delivery, and thus also stop the relative rotation between the dosing member 523 and the housing 532. The radial stopper 568 includes at least one stopper surface 569 provided at the dosing member 523 and a corresponding stopper surface 636 provided at the connector 527. The stopper surfaces 569, 636 are oriented parallel to each other and are configured to engage with each other at the end of the dose delivery. The stopper surfaces 569, 636 form a certain angle with a radial plane oriented perpendicular to the longitudinal axis of the dose delivery mechanism 554. For the third injection pen 500, the stopper surfaces 569, 636 are oriented parallel to the longitudinal axis. Although the stopper surface 636 is provided at the connector 527, for other embodiments, the stopper surface 636 may also be provided directly at the sleeve 528.
[0339] For the third injection pen 500, the adjustment element 518 forms a dose setting member of the dose delivery mechanism 554. To set the dose to be delivered, the user rotates the adjustment element 518 relative to the housing 532 in the assembled state.
[0340] Fig.68 A side view of the third injection pen 500 is depicted in an assembled state during dose setting when no dose is set. Fig.69 A side view of the third injection pen 500 in a pre-assembled state is depicted. In the pre-assembled state, the adjustment element 518 is located in a pre-assembly position relative to the housing 532, and in the assembled state during dose setting and without setting a dose, the adjustment element 518 is in an assembled position relative to the housing 532. Thus, the assembled position is located more proximally than the pre-assembly position.
[0341] Fig.70 shows a detailed view of a longitudinal section of the distal end of the third injection pen 500 in an assembled state during dose setting, and Fig.71 Another longitudinally cut detailed view of the distal end of the third injection pen 500 is shown in an assembled state during dose setting. Fig.71 The longitudinal section plane of the view shown in FIG. Fig.70 The longitudinal cutting plane orientation of the views shown in .
[0342] During dose setting, the setting element 518 is rotationally fixed relative to the coupling member 524 by the clutch mechanism 507. Thus, a rotation of the setting element 518 results in a rotation of the piston rod 44 due to the rotational fixation by the extension 525 and the coupling element 520, and a simultaneous rotation of the dosing member 523 due to the rotational fixation by the coupling element 520, the clutch mechanism 507 and the coupling member 524. Since both the piston rod 44 and the dosing member 523 rotate at the same speed relative to the housing 532 during dose setting, the piston rod 44 does not change its axial position relative to the housing 532 despite the threaded connection 189 between the piston rod 44 and the dosing member 523.
[0343] The rotation of the dosing member 523 relative to the sleeve 528 during dose setting causes the sleeve 528 to move axially in the distal direction relative to the housing 532 due to the threaded connection 562, 612. This also results in a distal movement of the adjustment element 518 and the coupling element 520. Furthermore, due to the axially fixed and rotationally movable connection to the sleeve 528 via the connector 527, the coupling member 524 is also moved distally.
[0344] As from Fig.70 and 71As can be seen, the adjustment element 518 is coupled to the sleeve 528 via a locking mechanism 597 that prevents the adjustment element 518 and the coupling element 520 from moving distally relative to the sleeve 528. Figures 58 to 61 , 63 and 64, the locking mechanism 597 includes a locking portion 600 located at the proximal end of the adjustment element 518, which engages with a locking counterpart 529 of the sleeve 528. The locking counterpart 529 of the sleeve 528 is configured as an annular edge located at the outer surface of the sleeve 528. The locking portion 600 of the adjustment element 518 is configured as a corresponding radial lug provided on the inner surface of the adjustment element 518. In the assembled position of the adjustment element 518, the radial lug 600 engages with the annular edge 529, thereby preventing the adjustment element 518 from moving further distally to the pre-assembled state.
[0345] The adjustment element 518 and the coupling element 520 are biased in the distal direction relative to the sleeve 528 by the biasing member 250, which is configured as a compression spring and Fig.48 is shown in Fig.70 and 71 Not visible in.
[0346] During dose setting, during rotation of the dosing member 523 and axial movement of the sleeve 528 relative to the housing 532, the window 610 of the sleeve 528 moves axially along the dosing member 523. Thereby, the corresponding marking on the dose sleeve 523 visible through the window 610 indicates the currently set dose.
[0347] To deliver a set dose, a user of the third injection pen 500 pushes the adjustment element 518 and the coupling element 520 in the proximal direction 1 against the force of the biasing member 250 .
[0348] Fig.72 shows a detailed view of a longitudinal section of the distal end of the third injection pen 500 in an assembled state during dose delivery, and Fig.73 Another detailed view of a longitudinal section of the distal end of the third injection pen 500 is shown in an assembled state during dose delivery, whereby the longitudinal section plane is perpendicular to Fig.73 The longitudinal cutting plane of the view in is oriented. Thus, Fig.72 , 73 The dose delivery mechanism 554 of the third injection pen 500 is shown at the end of dose delivery, when the set dose has been completely expelled and the user is still pressing the adjustment element 518 and the coupling element 520 in the proximal direction.
[0349] During dose delivery, the adjustment element 518 and the coupling element 520 are rotationally locked to the housing 532 via the sleeve 528. This is because the proximal movement of the coupling element 520 and the adjustment element 518 relative to the sleeve 528 at the start of dose delivery closes the clutch mechanism 513 between the adjustment element 518 and the sleeve 528. The clutch mechanism 513 includes teeth 515 formed at the adjustment element 518 and corresponding teeth 514 formed at the distal end of the sleeve 528. The clutch mechanism 513 also rotationally locks the piston rod 44 to the housing 532 via the extension 525, the coupling element 520, the adjustment element 518 and the sleeve 528 during dose delivery.
[0350] The proximal movement of the coupling element 520 relative to the coupling member 524 at the start of dose delivery causes the clutch mechanism 507 between the coupling element 520 and the coupling member 524 to be disconnected, so that the coupling member 524 becomes rotatable relative to the coupling element 520. After the clutch mechanism 507 is disengaged, the further proximal movement of the coupling element 520 pushes the sleeve 528 in the proximal direction 1. The proximal movement of the sleeve 528 causes the dosing member 523 to rotate via the threaded connection 612 between the sleeve 528 and the dosing member 523. Since the piston rod 44 is rotationally locked to the housing 332 during dose delivery, the rotation of the dosing member 523 causes the proximal movement of the piston rod 44, which is driven by the threaded connection 189.
[0351] Fig.74 A detailed view of a longitudinal section of the distal end of the third injection pen 500 is shown in a pre-assembled state of the dose delivery mechanism 554, and Fig.75 Another detailed view of a longitudinal section of the distal end of the third injection pen 500 in a pre-assembled state is shown, whereby the longitudinal section plane is perpendicular to Fig.74 Orients the longitudinal cutting plane of the view in .
[0352] In the pre-assembled state, the adjustment element 518 and the coupling element 520 are located in an adjustment position relative to the housing 532 and the sleeve 528. In this adjustment position, the adjustment element 518 and the coupling element 520 are displaced in the distal direction relative to their respective assembly positions in the assembled state.
[0353] The dose delivery mechanism 554 comprises another locking mechanism 599, which prevents the adjustment element 518 and the coupling element 520 from being separated in the pre-assembled state. The other locking mechanism 599 comprises a locking portion 600 of the adjustment element 518 and another locking counterpart 530 located at the distal end of the sleeve 528. Thus, the other locking counterpart 530 is located distally of the locking counterpart 529.
[0354] The other locking counterpart 530 is configured as an angular recess that receives the radial lug of the locking portion 600 of the adjustment element 518. Thus, the locking portion 600 formed by the radial lug is releasably engaged with the other locking counterpart 530 and allows proximal movement of the adjustment element 518 while preventing distal movement.
[0355] In the pre-assembled state, the clutch mechanism 507 between the coupling element 520 and the coupling member 524 is disconnected, so that the adjustment element 518 is rotationally separated from the dosing member 523. At the same time, the adjustment element 518 is rotationally coupled and rotationally fixed relative to the piston rod 44 by the coupling element 520 and the extension 525. The rotation of the adjustment element 518 relative to the housing 532 thus causes the piston rod 44 to rotate relative to the housing 532 and the dosing member 523. Due to the threaded connection 189 between the dosing member 523 and the piston rod 44, the piston rod 44 moves axially relative to the housing 332 when the adjustment element 518 rotates.
[0356] For the clutch mechanism 507, the coupling element 520 forms a first clutch member of the clutch mechanism 507 and the coupling member 524 forms a second clutch member of the clutch mechanism 507. The dosing member 523 of the dose delivery mechanism 554 forms a further member of the dose delivery mechanism 54, 354 to which the adjustment element 518 is rotationally coupled during dose setting in the assembled state and from which the adjustment element 518 is rotationally decoupled during dose delivery in the assembled state.
[0357] The coupling element 520 includes a first clutch portion 508 of the clutch mechanism 507. The first clutch portion 508 is configured as radial teeth disposed on an outer surface of the coupling element 520. The coupling member 524 includes a second clutch portion 509 of the clutch mechanism 507. The second clutch portion 509 is configured as radial teeth disposed on an inner surface of the coupling member 524. In the closed state of the clutch mechanism 507, the first clutch portion 508 is engaged with the second clutch portion 509, as shown in FIG. Fig.71 as shown in .
[0358] During adjustment of the piston rod in the pre-assembled state, the clutch mechanism 507 is in a disengaged state. Thereby, the first clutch part 508 and the second clutch part 509 are disengaged by positioning them axially spaced apart from each other. Thereby, the first clutch part 508 is displaced from the second clutch part 509 in a distal direction, which is opposite to the proximal direction 1, see Fig.74During dose delivery in the assembled state, the clutch mechanism 507 is also in the disengaged state. Thereby, the first clutch part 508 and the second clutch part 509 are also disengaged by positioning them axially spaced apart from each other, whereby the second clutch part 509 is displaced from the first clutch part 508 in the proximal direction 1, see Fig.72 .
[0359] Furthermore, the adjustment element 518 forms a first clutch member of the clutch mechanism 513 and the sleeve 528 forms a second clutch member of the clutch mechanism 513. The housing 532 of the dose delivery mechanism 554 forms an additional member of the dose delivery mechanism 554, to which the adjustment element 518 is rotationally coupled during dose setting in the assembled state and from which the adjustment element 518 is rotationally decoupled during dose delivery in the assembled state.
[0360] The sleeve 528 forms a retaining member for the adjustment element 518 .
[0361] The dose delivery mechanism 554 includes a dose limiting mechanism 115 which limits a dose that can be set by a user. The engagement feature 116 of the dose limiting mechanism 115 is disposed at the adjustment element 518, see Fig.58 The engagement feature 116 is configured as a radially extending lug which is flexible in the radial direction. The engagement feature 116 engages with a corresponding dose stop 118 provided at the distal end of the sleeve 528, see Fig.63 , 64 The dose stop 118 is configured as a longitudinal recess formed at the inner surface of the sleeve 528. During dose setting, the adjustment element 518 and the coupling element 520 are configured to perform more than one full rotation around the longitudinal axis of the dose delivery mechanism 554.
[0362] During adjustment of the piston rod 44 in the pre-assembled state, the dose limiting mechanism 115 of the dose delivery mechanism 554 is not functional. This is because the engagement feature 116 moves axially relative to the dose stop 118 to disengage the engagement feature 116 and the dose stop 118 from mutual engagement, see Fig.75 .
[0363] For the dose delivery mechanism 554, the housing 532 forms a third element and during adjustment of the piston rod in the pre-assembled state, the first threaded element formed by the piston rod 44 rotates relative to this third element, while the second threaded element formed by the dosing member 523 is rotationally fixed relative to this third element. During dose delivery in the assembled state, the first threaded element formed by the piston rod 44 is rotationally fixed relative to the third element formed by the housing 532, and the second threaded element formed by the dosing member 523 rotates relative to this third element.
[0364] For the third injection pen 500, the piston rod 44 may be configured to advance a first distance in the proximal direction 1 when the actuation member 520 moves proximally a second distance, wherein the second distance is less than 1.5 times the first distance. For the third injection pen 500, the ratio between the second distance and the first distance is given by the ratio of the pitch of the threaded connection 189 between the piston rod 44 and the dosing member 523 to the pitch of another threaded connection 562 between the sleeve 528 and the dosing member 523.
[0365] Additionally or alternatively, the third injection pen 500 may further include the drug reconstitution unit 56 of the first injection pen 10. Thus, such a third injection pen 500 may be configured to receive the dual-chamber cartridge 48 and perform reconstitution of the lyophilized drug prior to drug delivery.
[0366] Similar to the first injection pen 10, embodiments of the third injection pen 500 may be configured to prevent a user from prematurely activating the third injection pen 500. Similar to the first injection pen 10, embodiments of the third injection pen 500 may be configured to axially lock the actuation member 520 relative to the housing 532 before setting and delivering the first dose. Similar to the first injection pen 10, the third injection pen 500 may include a knob cover 16 and / or a knob key 30.
[0367] Fig.76 A perspective view of a fourth injection pen 700 according to the present disclosure is shown. The fourth injection pen 700 is a variant of the third injection pen 500. The fourth injection pen 700 is constructed as disclosed for the third injection pen 500 as long as the difference is not disclosed in the specification or the drawings. Hereinafter, components of the fourth injection pen 700 that perform the same functions as corresponding components of the third injection pen 500 are labeled with the same reference numerals. However, these components may be distinguished in shape and / or appearance between the third injection pen 500 and the fourth injection pen 700.
[0368] Fig.77 A side view of the fourth injection pen 700 is shown in an assembled state during dose setting. Thereby, no dose is set and the adjustment element 518 of the dose delivery mechanism 754 of the fourth injection pen 700 is in an assembled position relative to the housing 532 of the dose delivery mechanism 754 .
[0369] Fig.78 A side view of the fourth injection pen 700 in a preassembled state is shown, wherein the adjustment element 518 is in a preassembled position relative to the housing 532. In the preassembled position, the adjustment element 518 is moved from its assembly position in a distal direction, whereby the distal direction is oriented perpendicular to the proximal direction 1.
[0370] Fig.79A side view of a fourth injection pen in a pre-assembled state is shown, wherein the adjustment element 518 is in an adjustment position. In this adjustment position, the adjustment element 518 is moved in the proximal direction compared to the pre-assembled position.
[0371] Fig.80 An exploded view of a fourth injection pen 700 is shown, and Fig.81 A longitudinal section through the dose delivery mechanism 754 of the fourth injection pen 700 is shown in an assembled state during dose setting without setting a dose.
[0372] Similar to the dose delivery mechanism 554 of the third injection pen 500, the dose delivery mechanism 754 of the fourth injection pen 700 includes a coupling element 720 that is rotationally fixed and axially movable relative to the piston rod 44. Unlike the dose delivery mechanism 554, the dose delivery mechanism 754 does not have an extension 525. Instead, the coupling element 720 directly engages with the piston rod 44 to rotationally fix the coupling element 720 to the piston rod 44 and to allow axial movement between the coupling element 720 and the piston rod 44.
[0373] In addition, the dose delivery mechanism 754 also includes a biasing element in the form of a spring, which is not Fig.80 and 81 The biasing element biases the adjustment element 518 in the distal direction in both the pre-assembled state and the assembled state of the dose delivery mechanism 754.
[0374] Fig.82 A perspective view of the coupling element 720 of the dose delivery mechanism 754 is shown, and Fig.83 Shown along Fig.82 4. A radial cross-sectional view of the coupling element 720 along line AA is shown in FIG. The coupling element 720 is configured as a tubular member extending in the longitudinal direction. It has a non-circular inner cross-section configured to receive the piston rod 44. Fig.84 The piston rod 44 shown in FIG. 4 has a distal section 45 having a profile configured to engage with a non-circular inner cross-section of a coupling element 720 to rotationally lock the piston rod 44 and the coupling element 720 and allow axial movement between the coupling element 720 and the piston rod 44 .
[0375] Figures 85 to 89The adjustment element 518 of the dose delivery mechanism 754 is depicted. The adjustment element 518 engages with a distal portion of the coupling element 720. Thus, the adjustment element 518 is rotationally fixed relative to the coupling element 720 in both the pre-assembled state and the assembled state of the dose delivery mechanism 704. The rotation lock between the coupling element 720 and the adjustment element 518 includes a non-circular outer cross-section of the coupling element 720 that matches and engages with a corresponding inner shape of the central opening 519 of the adjustment element 518.
[0376] The locking mechanism 597 acts between the coupling element 720 and the adjustment element 518. In the assembled state of the dose delivery mechanism 754, the locking mechanism 597 prevents the adjustment element 518 from moving distally from the assembly position to the pre-assembly position relative to the housing 532. The locking mechanism 597 includes a locking portion 600 formed at the adjustment element 518 and a locking corresponding portion 529 formed at the coupling element 720. The locking portion 600 is configured as a flexible hook, which protrudes radially inward from the inner surface of the adjustment element 518 at the opening 519. The locking corresponding portion 529 is configured as a recessed portion at the outer surface in the distal portion of the coupling element 720.
[0377] The coupling element 720 may form a retaining member of the dose delivery mechanism 754 .
[0378] In the pre-assembled state of the dose delivery mechanism 754, the adjustment element 518 is located at a more distal position relative to the coupling element 720 than in the assembled state. In this position, the adjustment element 518 is prevented from being separated from the dose delivery mechanism 754 and the coupling element 720 by the further locking mechanism 599. The further locking portion of the further locking mechanism 599 is formed by the locking portion 600, and the further locking counterpart 530 of the further locking mechanism 599 is formed by an additional recess at the outer surface of the coupling element 720. Thus, the further locking counterpart 530 is located at the distal side of the locking counterpart 529.
[0379] Figure 90 to Figure 93 A sleeve 528 of a dose delivery mechanism 754 is shown that is rotationally fixed and axially movable relative to a housing 532. The sleeve 528 includes longitudinal recesses on its outer surface that engage corresponding longitudinal ridges on the inner surface of the housing 532 to rotationally fix the sleeve 528 to the housing 532. The sleeve 528 includes an outer portion 528a and an insert 528b that is rotationally and axially fixed within the outer portion 528a at a distal end of the outer portion 528a.
[0380] The dose limiting mechanism 115 of the dose delivery mechanism 754 acts between the adjustment element 518 and the sleeve 528. The dose limiting mechanism 115 includes an engagement feature 116 configured as a flexible hook and disposed at the proximal end of the adjustment element 518. The engagement feature 116 interacts with a dose stop 118 disposed in a proximal portion of the inner surface of the insert 528b of the sleeve 528.
[0381] Furthermore, the dose delivery mechanism 754 comprises a clutch mechanism 513 acting between the adjustment element 518 and the sleeve 528. The clutch mechanism 513 comprises teeth 515 located at the proximal outer surface of the adjustment element 518. When the clutch mechanism 513 is closed, the teeth 515 engage with corresponding teeth 514 provided in the distal portion of the inner surface of the insert 528b. Thus, the inner surface is the side surface of the cavity formed at the distal end of the insert 528b and the sleeve 528.
[0382] The adjustment element 518 forms a first clutch member of the clutch mechanism 513, and the sleeve 528 forms a second clutch member of the clutch mechanism 513. The housing 532 of the dose delivery mechanism 754 forms an additional component of the dose delivery mechanism 754, to which the adjustment element 518 is rotationally coupled during dose setting in the assembled state, and from which the adjustment element 518 is rotationally decoupled during dose delivery in the assembled state. Furthermore, the clutch mechanism 513 forms a locking mechanism, which rotationally locks the adjustment element 718 to the housing 532 during dose delivery in the assembled state of the dose delivery mechanism 754.
[0383] Figures 94 to 96 The coupling member 524 of the dose delivery mechanism 754 is shown. The coupling member 524 is axially fixed to the sleeve 528 by a rim 592 provided at the distal end of the coupling member 524. The rim 592 is held between a proximal blocking element 634 and a distal blocking element 635 provided at the proximal end of the insert 528b. The proximal blocking element 634 is configured as a flexible hook, and the distal blocking element 635 is formed by a radial surface of the insert 528b.
[0384] The clutch mechanism 507 acts between the coupling member 524 and the coupling element 720 received in the coupling member 524. The clutch mechanism 507 comprises a first clutch portion 508, which is located on the outer surface of the coupling element 720 and comprises longitudinal teeth. The clutch mechanism 507 further comprises a second clutch portion 509, which is located on the inner surface of the coupling member 524. The second clutch portion 509 is configured as longitudinal teeth, which mesh with the longitudinal teeth of the first clutch portion 508 in the closed state of the clutch.
[0385] The coupling element 520 forms a first clutch member of the clutch mechanism 507 and the coupling member 524 forms a second clutch member of the clutch mechanism 507. The dosing member 523 of the dose delivery mechanism 754 forms a further member of the dose delivery mechanism 754 to which the adjustment element 518 is rotationally coupled during dose setting in the assembled state and from which the adjustment element 518 is rotationally decoupled during dose delivery in the assembled state.
[0386] Fig.97 and 98 The dosing member 523 of the dose delivery mechanism 754 is shown. A radial stop 568 is provided between the dosing member 523 and the insert 528b of the sleeve 528. The radial stop 568 comprises a stop surface 636 at the proximal extension of the insert 528b and a corresponding stop surface 569 at the distal end of the dosing member 523.
[0387] As from Fig.99 and Fig.100 As can be seen, the Fig.99 and Fig.100 The dose delivery mechanism 754 is shown in an assembled state during dose setting without setting a dose, during which the clutch mechanism 507 between the coupling element 720 and the coupling member 524 is closed, and the clutch mechanism 513 between the adjustment element 518 and the sleeve 528 is opened. Dose setting is then achieved by rotating the adjustment element 720 in the same manner as described for the third injection pen 500.
[0388] Fig.101 and 102 The dose delivery mechanism 754 is depicted in an assembled state during dose delivery when the set dose has been completely expelled and the user still pushes the adjustment element 518 in the proximal direction 1. During dose delivery, the clutch mechanism 507 is opened, thereby allowing rotation between the piston rod 44 and the dosing member 523, and the clutch mechanism 513 is closed, thereby rotationally locking the piston rod 44 to the housing 532.
[0389] Fig.103 and 104 The dose delivery mechanism 754 is depicted in a pre-assembled state. Compared to the assembled state, the adjustment element 518 is moved in the distal direction relative to the coupling element 720 and the housing 532. As a result, the locking portion 600 of the adjustment element 518 engages with another locking counterpart 530 disposed distally of the locking counterpart 529 at the coupling element 720. Fig.103 and 104 In the state depicted in , the adjustment element 518 is located in a pre-assembly position relative to the housing 532 .
[0390] In order to adjust the position of the piston rod 44 in the pre-assembled state, the adjustment element 518 is pushed from the pre-assembled position to the adjustment position in the proximal direction 1 against the biasing force of the spring acting between the adjustment element 518 and the sleeve 528, as shown in FIG. Fig.105 and 106 . The proximal movement of the adjustment element 518 causes the proximal movement of the coupling element 720 and causes the disconnection of the clutch mechanism 507. At the same time, the clutch mechanism 513 remains disconnected and prevents the teeth 515 of the adjustment element 518 from engaging with the teeth 514 of the sleeve 528. This is due to the axial offset between the teeth 513 and the teeth 514.
[0391] When the assembler of the fourth injection pen 700 rotates the adjustment element 518 to Fig.105 and 106 In the adjustment position depicted in FIG, the piston rod 44 rotates with the adjustment element 518, and the dosing member 523 does not rotate due to the disconnected clutch mechanism 507. Thus, the rotation of the piston rod 44 relative to the dosing member 523 causes the piston rod 44 to move axially relative to the housing 532 via the threaded connection 189.
[0392] For the fourth injection pen 700, the piston rod 44 may be configured to advance a first distance in the proximal direction 1 when the actuation member 518 moves proximally a second distance, wherein the second distance is less than 1.5 times the first distance. For the fourth injection pen 700, the ratio between the second distance and the first distance is given by the ratio of the pitch of the threaded connection 189 between the piston rod 44 and the dosing member 523 to the pitch of another threaded connection 562 between the sleeve 528 and the dosing member 523.
[0393] Additionally or alternatively, the fourth injection pen 700 may further include the drug reconstitution unit 56 of the first injection pen 10. Thus, such a fourth injection pen 700 may be configured to receive the dual-chamber cartridge 48 and perform reconstitution of the lyophilized drug prior to drug delivery.
[0394] Similar to the first injection pen 10, embodiments of the fourth injection pen 700 may be configured to prevent a user from prematurely activating the fourth injection pen 700. Similar to the first injection pen 10, embodiments of the fourth injection pen 700 may be configured to axially lock the actuation member 520 relative to the housing 532 before setting and delivering the first dose. Similar to the first injection pen 10, the fourth injection pen 700 may include a knob cover 16 and / or a knob key 30.
[0395] The mechanism may include a dose limiting mechanism that allows a user of the device to set at least one dose of the drug for delivery. For example, the dose limiting mechanism may be configured to allow only a single predetermined dose to be set. Alternatively, the dose limiting mechanism may also be configured to allow a user to set a plurality of different predetermined doses, such as two or more different doses.
[0396] For the injection pen 10, 300, 500, 700, the dose delivery mechanism 54, 354, 554, 754 each comprises a dose limiting mechanism 115, wherein the respective dose limiting mechanism 115 acts between the respective dose setting element 18, 318, 518 and the housing 32, 332, 532 during dose setting. Thereby, the dose limiting mechanism 115 has at least one dose stop 118 and a corresponding element 116, wherein the corresponding element 116 is configured to rotate relative to the dose stop 118 when the dose setting element 38, 318, 518 is rotated during dose setting, and wherein the corresponding element 116 is configured to engage the dose stop 118 when the dose has been set. The corresponding element 116 is formed by a respective engagement feature 116 of the dose delivery mechanism 54, 354, 554, 754.
[0397] The dose limiting mechanism 115 may define a rotational position of the dose setting element 22, 518 relative to the housing 32, 332, 532 corresponding to a settable dose. For each settable dose, the dose limiting mechanism 115 may include a separate dose stop 118. Thus, the dose setting element 22, 518 may be configured to perform less than one full rotation during dose setting. For the third and fourth injection pens 500, 700, the dose limiting mechanism 115 may also include a discrete dose stop 118 defining more than a single dose, for example, the discrete dose stop 118 may be configured to engage with the corresponding element 116 once for each full rotation of the corresponding element 116 relative to the dose stop 118.
[0398] The corresponding element 116 may be configured as a flexible element that snaps onto the dose stop 118 when setting a dose. For example, the corresponding element 116 may be configured as a flexible protrusion at a component of the corresponding dose delivery mechanism 54, 354, 554, 754. For example, the corresponding element 116 may be formed integrally with the component of the corresponding dose delivery mechanism 54, 354, 554, 754 to which it is fixed. For the first and second injection pens 10, 300, the component is formed by the dosing member 23, 323, while for the third and fourth injection pens 500, 700, it is formed by the dose setting element 518.
[0399] For the first and second injection pens 10, 300, the engagement of the corresponding element 116 with the dose stop 118 prevents the spring 40 from releasing energy stored during dose setting when the dose setting element 22 is rotated. Thereby, the dose limiting mechanism 115 may provide a lock function, which holds the spring 40 in a tensioned state until a dose is delivered by switching the corresponding dose delivery mechanism 54, 354 from a dose setting state to a dose delivery state.
[0400] For the first and second injection pens 10, 300, the corresponding element 116 is configured to disengage from the dose stop 118 when the corresponding dose delivery mechanism 54, 354 is switched from the dose setting state to the dose delivery state. This prevents the dose limiting mechanism 115 from interfering with the delivery of the set dose. In addition, it may allow the spring 40 to release energy stored when rotating during dose setting. For embodiments with more than a single dose stop 118, the corresponding element 116 may be configured to disengage from all dose stops 118 when the corresponding dose delivery mechanism 54, 354 is switched to the dose delivery state. This may allow the corresponding element 116 to rotate back to its initial position during dose delivery without interfering with the dose stop 118. The initial position may correspond to a zero dose position where no dose is set.
[0401] For example, the corresponding element 116 may be configured to disengage from the dose stop 118 by being axially moved relative to the dose stop 118 .
[0402] For the injection pen 10, 300, 500, 700, one of the dose stop 118 and the corresponding element 116, for example the dose stop 118, is rotationally fixed relative to the housing 32, 332, 532. One of the dose stop 118 and the corresponding element 116 is then axially movable relative to the dose setting element 22, 518.
[0403] For the first and second injection pens 10, 300, the one of the dose stop 118 and the corresponding element 116, e.g. the dose stop 118, is axially fixed relative to the button 18, 318. This allows the one of the dose stop 118 and the corresponding element 116 to be moved together with the button 18, 318 when the corresponding dose delivery mechanism 54, 354 is switched from a dose setting state to a dose delivery state. The one of the dose stop 118 and the corresponding element 116 may then be disengaged from the other of the dose stop 118 and the corresponding element 116 by this movement. For example, the one of the dose stop 118 and the corresponding element 116 may be linearly guided at the housing 32, 332.
[0404] For some embodiments, the one of the dose stop 118 and the corresponding element 116 is fixed to an outer housing part of the respective dose delivery mechanism 54, 354, 554, 754. The outer housing part may be fixed to a connection for coupling the drug container 48, 348 to the respective dose delivery mechanism 54, 354, 554, 754. Alternatively, the outer housing part may also be movable relative to the connection, for example axially movable. In addition, the outer housing part may be rotationally fixed relative to the connection. For example, the outer housing part may be a housing connector, for example a housing connector engaged with the housing 32, 332, 532 by an axially movable and rotationally fixed connection. For the first and second injection pens 10, 300, the outer housing part is formed by the dose selector 28, and for the third and fourth injection pens 500, 700, it is formed by the sleeve 528.
[0405] For the first and second injection pens 10, 300, the dose limiting mechanism 115 acts between the dosing member 23, 332 and the housing 32, 332, 532. It then defines a rotational position of the dosing member 23, 332 relative to the housing 32, 332 corresponding to a settable dose.
[0406] For the first and second injection pens 10, 300, the other of the dose stop 118 and the corresponding element 116, e.g. the corresponding element 116, is rotationally fixed relative to the dosing member 23, 332. Exemplarily, the other of the dose stop 118 and the corresponding element 116 is permanently rotationally fixed relative to the dosing member 23, 332. The other of the dose stop 118 and the corresponding element 116 is exemplarily additionally fixed to the dosing member 23, 332, e.g. fixed to a first part of the dosing member 23, 332 that is movable relative to the housing 32, 332, 532.
[0407] For the first, second, third and fourth injection pens 10, 300, 500, 700, the other of the dose stop 118 and the corresponding element 116, e.g. the corresponding element 116, is axially movable relative to the button 18, 318, 518. The one of the dose stop 118 and the corresponding element 116, e.g. the dose stop 118, is axially fixed relative to the button 18, 318, 518. This allows the dose stop 118 to be disengaged from the corresponding element 116 by moving the button relative to the housing 32, 332, 532, just as in the case of the first and second injection pens 10, 300.
[0408] For the second injection pen 300, the dose delivery mechanism 354 includes a blocking mechanism having a first element and a second element, wherein when the button 318 is released during dose delivery, the first element engages the second element to prevent the corresponding dose delivery mechanism 354 from changing from the dose delivery state to the dose setting state. This keeps the corresponding dose delivery mechanism 354 in the dose delivery state and prevents the dose setting from changing when the dose delivery is interrupted due to the torque provided by the spring 40. The blocking mechanism can resist the distal movement of the button 318 against the biasing force that biases the button 318 in the distal direction. The biasing force can be provided by the biasing element 250.
[0409] The blocking mechanism is configured to disengage the first element from the second element at the zero dose position where the set dose has been fully delivered. This allows the dose delivery mechanism 354 to return to the dose setting state so that a subsequent dose can be set after the previous drug delivery is completed.
[0410] Exemplarily, the first element rotates in a first direction relative to the second element during dose setting, and rotates in a second direction opposite to the first direction during dose delivery. The relative movement between the first and second elements may bring the first and second elements into a relative position which prevents mutual engagement at the end of dose delivery and / or when a dose has been set.
[0411] For the second injection pen 300 , the first element is configured as a circumferential rib 156 extending longitudinally around the axis of the housing 332 , and the second element is configured as a stopper or corresponding element formed by the engagement feature 116 of the snap element 24 , which travels along the circumferential rib 124 during dose delivery.
[0412] Exemplarily, when the button 318 is released at the end of the dose delivery, the second element passes the first element. For example, the second element can pass through an opening in the first element. At the end of the dose delivery, the second element can be rotated to align with the opening.
[0413] Additionally or alternatively, the blocking mechanism may be configured to prevent the dose delivery mechanism 354 from transitioning from the dose setting state to the dose delivery state unless the dose has been set. Such a blocking mechanism is also exemplarily implemented in the dose delivery mechanism 54 of the first injection pen 10. Exemplarily, when the dose delivery mechanism 54, 354 transitions from the dose setting state to the dose delivery state, the second element passes through the first element. Exemplarily, the second element passes through one of the openings or cutouts 158 in the first element. When the dose has been set, the second element is exemplarily rotated to align with the opening 158.
[0414] Illustratively, when the mechanism is switched from a dose setting state to a dose delivery state, the second element passes through one of the openings or cutouts 158 in the first element. Such an opening 158 prevents obstruction and thus allows axial movement of the button 18, 318 to initiate dose delivery.
[0415] Exemplarily, the first element of the blocking mechanism and one of the dose stop 118 and the corresponding element 116, e.g. the dose stop 118, are fixed to the same component of the dose delivery mechanism 54, 354. Furthermore, the second element of the blocking mechanism and the other of the dose stop 118 and the corresponding element 116, e.g. the corresponding element 116, are fixed to the same other component of the dose delivery mechanism 54, 354. This allows precise alignment of the elements of the blocking mechanism and the elements of the dose limiting mechanism 115, and enhances the reliability of the dose delivery mechanism 54, 354.
[0416] The mechanism component including the first element of the blocking mechanism and the one of the dose stop 118 and the corresponding element 116 is exemplarily a dose selector 28 of the dose delivery mechanism 54, 354. The other component of the dose delivery mechanism 54, 354 including the second element of the blocking mechanism and the other of the dose stop 118 and the corresponding element 116 is exemplarily a carrier that is rotatably movable relative to the dose selector 28. The carrier is exemplarily a part of the metering supply component 23, 332, that is, it is constituted by the snap element 24 of the metering supply component 23, 323.
[0417] The dose selector 28 is illustratively located at least partially within the outer housing of the dose delivery mechanism 54, 354, ie, the housing 32, 332. The dose selector 28 is illustratively configured to protrude from the outer housing.
[0418] Exemplarily, one of the first and second elements of the blocking mechanism and one of the dose stop 118 and the corresponding element 118 are formed by a single element. As an example, the second element of the blocking mechanism and the corresponding element 116 of the dose limiting mechanism 115 are formed by a single element. This facilitates alignment of the components of the blocking mechanism relative to the components of the dose limiting mechanism 115.
[0419] The single element is exemplarily a flexible element which is configured to snap onto the dose stopper 118 when rotated relative to the dose stopper 118 .
[0420] For the first and second injection pens 10, 300, the dose delivery mechanism 54, 354 comprises a maximum dose mechanism which limits further rotation of the dose setting element 22 when the maximum dose setting is dialed, wherein the maximum dose mechanism comprises a maximum dose stop 126, exemplarily formed by a hard stop 128, and a blocking portion 124, exemplarily formed by a hard stop 124, and wherein the blocking portion 124 is configured to engage the maximum dose stop 126, 128 when the maximum dose setting is dialed. This provides a well-defined rotation end position of the dose setting element 22. The maximum dose stop 126, 128 can also absorb torque provided by the user and direct the torque to the housing 32, 332 of the dose delivery mechanism 54, 354.
[0421] The blocking portion 124 illustratively engages the maximum dose stop 126, 128 just at the maximum dose setting. For other embodiments, the blocking portion 124 may engage the maximum dose stop 126, 128 only after the maximum dose setting is dialed a predetermined amount.
[0422] The blocking portion 124 is exemplarily configured as a hard stop that is rigidly connected to a component of the mechanism, such as being integrally formed. Likewise, the maximum dose stops 126, 126 are exemplarily configured as such a hard stop.
[0423] Illustratively, the maximum dose stop 126 and the blocking portion 124 are configured to rotate relative to each other during dose setting. As an example, one of the maximum dose stop 126, 126 and the blocking portion 124, i.e., the maximum dose stop 126, 126, may be rotationally fixed relative to the housing 32, 332 during dose setting, and the other of the maximum dose stop 126, 126 and the blocking portion 124, e.g., the blocking portion 124, may be rotationally fixed relative to the dose setting member 22 during dose setting. The other of the maximum dose stop 126, 126 and the blocking portion 124 may be rotationally movable relative to the dose setting member 22 during dose delivery.
[0424] Exemplarily, the maximum dose stop 126 is configured as a radial stop and the blocking portion 124 is configured to rotate against the maximum dose stop 126 when the maximum dose is dialed. Such a radial stop provides a well-defined rotational position in which the blocking portion 124 and the maximum dose stop 126 engage.
[0425] The maximum dose stopper 126 and the blocking portion 124 exemplarily comprise engagement surfaces that engage with each other. The engagement surfaces are exemplarily oriented substantially perpendicularly, ie perpendicularly, to a circumferential direction around the longitudinal axis of the dose delivery mechanism 54,354.
[0426] Illustratively, one of the maximum dose stop 126 and the blocking portion 124, e.g. the maximum dose stop 126, is rotationally fixed relative to the housing 32, 332. The one of the maximum dose stop 126 and the blocking portion 124 is illustratively permanently rotationally fixed relative to the housing 32, 332 both during dose setting and dose delivery.
[0427] Exemplarily, the one of the maximum dose stopper 126 and the blocking portion 124 is fixed to an outer housing portion of the dose delivery mechanism 54, 354. The outer housing portion is exemplarily configured as a housing connector between the dose setting element 22 and the housing 32, 332 of the injection pen 10, 300. The outer housing portion is configured as a dose selector 28.
[0428] Exemplarily, the other of the maximum dose stop 126 and the blocking portion 124, for example the blocking portion 124, is rotationally fixed relative to the dosing member 23, 332. Then, the other of the maximum dose stop 126 and the blocking portion 124 rotates relative to the housing 332, 32 during both dose setting and dose delivery. This allows the maximum dose mechanism to be reset during dose delivery. For embodiments in which the rotational position of the dosing member 23, 332 defines the set dose, rotationally fixing the one of the maximum dose stop 126 and the blocking portion 124 to the dosing member 23, 332 precisely defines the maximum dose position in which the maximum dose stop 126 and the blocking portion 124 engage with each other.
[0429] Exemplarily, the other of the maximum dose stop 126 and the blocking portion 124 is fixed to a coupling member which rotationally couples the dosing member 23 , 332 to the dose setting element during dose setting. The coupling member is formed by the snap element 24 .
[0430] Exemplarily, one of the dose stop 118 and the corresponding element 116, e.g. the dose stop 118, and one of the maximum dose stop 126 and the blocking portion 124, e.g. the maximum dose stop 126, are fixed to the same component of the dose delivery mechanism 54, 354. This allows the relative position of the components of the dose limiting mechanism 115 relative to the components of the maximum dose mechanism to be precisely defined. The component of the dose delivery mechanism 54, 354 is exemplarily the dose selector 28.
[0431] Exemplarily, the other of the dose stop 118 and the corresponding element 116, such as the corresponding element 116, and the other of the maximum dose stop 126 and the blocking portion 124, such as the blocking portion 124, are fixed to the same other component of the dose delivery mechanism 54, 354. This also allows the relative position of the components of the dose limiting mechanism 115 relative to the components of the maximum dose mechanism to be accurately defined. For example, the other component can be a carrier that is rotatably movable relative to the dose selector 28 and is formed by the snap element 24.
[0432] Exemplarily, the dose delivery mechanism 54, 354 of the first and second injection pens 10, 300 comprises a zero dose mechanism that prevents further axial movement of the nut 38 at the end of dose delivery, wherein the zero dose mechanism comprises a zero dose stop and a further blocking portion, and wherein the further blocking portion is configured to engage the zero dose stop at the end of dose delivery. This provides a clearly defined end position for the piston rod 44 at the end of dose delivery and thus helps to accurately define the amount of drug delivered.
[0433] For the first injection pen 10, the zero dose stop is formed by the end stop 176 at the guide 42 of the piston rod 44, and the further blocking portion is formed by the end stop 174 at the driver 36. For the second injection pen 300, the zero dose stop is formed as a protrusion on the inner surface of the dose selector 28, and the further blocking portion is formed by the hard stop 124 at the snap element 24.
[0434] The further blocking portion 124, 174 is exemplarily configured as a hard stop, which is rigidly connected, for example integrally formed, to a component of the dose delivery mechanism 54, 354. Likewise, the zero dose stop 176 is exemplarily configured as such a hard stop.
[0435] Exemplarily, the zero dose stop 176 and the further blocking portion 124, 174 are configured to rotate relative to each other during dose delivery. For example, the zero dose stop 176 and one of the further blocking portions 124, 174, e.g. the zero dose stop 176, are rotationally fixed relative to the housing 32, 332 during dose setting, and the zero dose stop 176 and the other of the further blocking portions 124, 174, e.g. the other blocking portion 124, 174, are rotationally fixed relative to the dose setting element 22 during dose setting. The zero dose stop 176 and the other of the further blocking portions 124, 174 are exemplarily rotationally movable relative to the dose setting element 22 during dose delivery.
[0436] Exemplarily, the zero dose stop 176 is configured as a radial stop and the further blocking part 124, 174 is configured to rotate against the zero dose stop 176 at the end of dose delivery. Such a radial stop provides a well-defined rotational position in which the further blocking part 124, 174 and the zero dose stop 176 come into engagement with each other.
[0437] The zero dose stopper 176 and the further blocking portion 124, 174 exemplarily comprise engagement surfaces engaging each other. These engagement surfaces may be oriented substantially perpendicularly, for example perpendicularly, to a circumferential direction around the longitudinal axis of the dose delivery mechanism 54, 354.
[0438] Exemplarily, the zero dose stop 176 and one of the further blocking parts 124, 174, e.g. the zero dose stop 176, are rotationally fixed relative to the housing 32, 332. The zero dose stop 176 and the one of the further blocking parts 124, 174 are exemplarily permanently rotationally fixed relative to the housing 32, 332 both during dose setting and dose delivery.
[0439] Exemplarily, the zero-dose stopper 176 and the one of the further blocking portions 124, 174 are fixed to an outer housing portion of the dose delivery mechanism 54, 354. For the second injection pen 300, the outer housing portion is exemplarily configured as a housing connector between the dose setting element 22 and the housing 332 of the second injection pen 300. Furthermore, the first injection pen 10 may alternatively include such a zero-dose stopper 176.
[0440] Exemplarily, the zero dose stop 176 and the other of the further blocking parts 124, 174 are rotationally fixed relative to the dosing member 23, 332. The zero dose stop 176 and the other of the further blocking parts 124 are then rotated relative to the housing 32, 332 during both dose setting and dose delivery. This allows the zero dose mechanism to be reset during dose setting. For embodiments in which the rotational position of the dosing member 23, 332 defines the set dose, the zero dose stop 176 and the one of the further blocking parts 124, 174 being rotationally fixed to the dosing member 23, 332 precisely defines the zero dose position in which the zero dose stop and the further blocking part 124 engage with each other.
[0441] For the second injection pen 200, the zero dose stopper 176 and the other of the further blocking portions 124, 174 are fixed to a coupling member which rotationally couples the dosing member 23, 332 to the dose setting member 22 during dose setting. The coupling member is formed by the snap element 24 of the dosing member 323. The first injection pen 10 may also include such a configuration.
[0442] Exemplarily, one of the dose stopper 118 and the corresponding element 116 of the second injection pen 300, for example the dose stopper 118, and one of the zero dose stopper and the further blocking portion 124 of the second injection pen 300, for example the zero dose stopper, are fixed to the same component of the dose delivery mechanism 354. This allows the relative position of the components of the dose limiting mechanism 115 relative to the components of the zero dose mechanism to be precisely defined. The component of the dose delivery mechanism 354 is exemplarily the dose selector 28. The first injection pen 10 may also have such a configuration.
[0443] Exemplarily, the other of the dose stop 118 and the corresponding element 116 of the second injection pen 300, such as the corresponding element 116, and the other of the zero dose stop and the further blocking portion 124 of the second injection pen 300, such as the further blocking portion 124, are fixed to the same further component of the dose delivery mechanism 354. This also allows the relative position of the components of the dose limiting mechanism 115 relative to the components of the zero dose mechanism to be accurately defined. For example, the further component may be a carrier that is rotatably movable relative to the dose selector 28. The first injection pen 10 may also have such a configuration.
[0444] Exemplarily, the second injection pen 300, the maximum dose stopper 126 of the maximum dose mechanism and one of the blocking portions 124, and the zero dose stopper and the other blocking portion 124 of the zero dose mechanism, such as the maximum dose stopper 126 and the zero dose stopper, are fixed to the same component of the mechanism. In addition, the maximum dose stopper 126 of the maximum dose mechanism and the other of the blocking portions 124, and the zero dose stopper and the other of the blocking portions 124 of the zero dose mechanism, such as the blocking portion 124 and the other blocking portion 124, are fixed to the same other component of the mechanism. This provides precise alignment between the components of the maximum dose mechanism and the components of the zero dose mechanism. The first injection pen 10 may also have such a configuration.
[0445] Regardless of whether they are fixed to the same component of the mechanism, the maximum dose stopper 126 and / or the minimum dose stopper may be integrally formed with the component to which they are fixed. Similarly, the blocking portion 124 and / or the further blocking portion 124 may be integrally formed with the component to which they are fixed.
[0446] Exemplarily, for the second injection pen 300, the blocking portion 124 of the maximum dose mechanism forms the further blocking portion 124 of the minimum dose mechanism. This allows the distance between the maximum dose position and the zero dose position to be precisely defined. The first injection pen 10 may also have such a configuration.
[0447] In general, the dose delivery mechanism 54, 354, 554, 754 may include a clutch mechanism 113 having a first engagement portion and a second engagement portion, wherein the clutch mechanism 113 is closed during one of dose setting and dose delivery, and is open during the other of dose setting and dose delivery. When the first engagement portion and the second engagement portion are not engaged with each other, the clutch mechanism 113 is in an open state, and when the first engagement portion and the second engagement portion are engaged with each other, the clutch mechanism 113 is in a closed state.
[0448] Illustratively, the dose delivery mechanism 54, 354 of the first and second injection pens comprises a clutch mechanism 113, wherein the clutch mechanism 113 rotationally locks the nut 38 to the piston rod 44 during dose delivery and rotationally releases the nut 38 from the piston rod 44 during dose setting. By rotationally locking the nut 38 to the piston rod 44, the clutch mechanism 113 forces the nut 38 to move proximally together with the piston rod 44. Illustratively, the clutch mechanism 113 rotationally locks the threaded connection 189 coupling the nut 38 to the piston rod 44. The clutch mechanism 113 locks the nut 38 to the piston rod 44 in a closed state and rotationally releases the nut 38 from the piston rod 44 in an open state.
[0449] The clutch mechanism 113 exemplarily comprises a first engagement portion and a second engagement portion, and the first engagement portion and the second engagement portion are configured to engage with each other to rotationally lock the nut 38 to the piston rod 44. The first engagement portion and the second engagement portion are exemplarily configured to disengage from each other by relative axial movement relative to each other. The first engagement portion is exemplarily formed by the teeth 114 of the connector 26, and the second engagement portion is exemplarily formed by the teeth 108 of the dose setting element 22.
[0450] The clutch mechanism 113 is illustratively configured to switch from the open state to the closed state when the button 18, 318 moves and the dose delivery mechanism 54, 354 switches from the dose setting state to the dose delivery state. One of the first engagement portion and the second engagement portion, such as the second engagement portion, is axially fixed relative to the button 18, 318, and the other of the first engagement portion and the second engagement portion, such as the first engagement portion, is axially fixed relative to the housing 32, 332. Additionally or alternatively, the first engagement portion is axially fixed relative to the metering member 23, 332.
[0451] Exemplarily, the first engagement portion is rotationally fixed to the housing 32 , 332 , and the second engagement portion is rotationally fixed to the nut 38 .
[0452] The second engagement portion is exemplarily rotationally fixed to the button 18 , 318 and / or the dose setting element 22 .
[0453] Illustratively, the clutch mechanism 113 rotationally secures the nut 38 to the piston rod 44 via the housing 32 , 332 and, for example, via the dose setting element 22 and / or the button 18 , 318 during dose delivery.
[0454] Illustratively, the clutch mechanism 113 acts between the button 1 , 318 and the housing 32 , 332 and / or between the dose setting member 22 and the housing 32 , 332 .
[0455] Exemplarily, the button 18, 318 is rotationally coupled, for example permanently rotationally coupled, to one of the first engagement portion and the second engagement portion. As an example, the button 18, 318 constitutes the one of the first engagement portion and the second engagement portion.
[0456] Exemplarily, the dose delivery mechanism 54, 354 comprises a further clutch mechanism 107, wherein the further clutch mechanism 107 rotationally locks the dose setting element 22 to one end of the spring 40 during dose setting and decouples the dose setting element 22 from the one end of the spring 40 during dose delivery. Furthermore, the further clutch mechanism 107 has a further first engagement portion and a further second engagement portion, wherein the further first engagement portion is configured to move into engagement with the further second engagement portion to rotationally lock the dose setting element 22 to the one end of the spring 40. The further clutch mechanism 107 allows the spring 40 to be tightened during dose setting and at the same time prevents the dose setting element 22 from rotating during dose delivery when the spring 40 is relaxed again. The further first engagement portion is exemplarily formed by teeth 110 at the catch element 23, and the further second engagement portion is exemplarily formed by teeth 108 at the button 22.
[0457] By the movement of the button 18, 318, the other clutch mechanism 107 is exemplarily transformed from a closed state, in which the other first engagement portion is engaged with the other second engagement portion, to an open state, in which the other first engagement portion is disengaged from the other second engagement portion. The movement of the button 18, 318 is exemplarily a movement that transforms the dose delivery mechanism 54, 354 from a dose setting state to a dose delivery state.
[0458] Exemplarily, one of the further first engagement portion and the further second engagement portion, for example the further second engagement portion, is rotationally and axially fixed to the dose setting member 22. This allows opening and closing of the further clutch mechanism 107 by relative movement of the dose setting member 22 relative to the other of the further first engagement portion and the further second engagement portion.
[0459] Exemplarily, said one of the further first engagement portion and the further second engagement portion is rotationally and axially fixed to the button 18, 318. Thereby, the dose setting member 22 is at least rotationally fixed to the button 18, 318.
[0460] Exemplarily, the further clutch mechanism 107 acts between the dosing member 23, 332 and the dose setting element 22. The dosing member 23, 332 can then rotationally couple the dose setting element 22 onto one end of the spring 40.
[0461] Exemplarily, one of the further first engagement portion and the further second engagement portion, for example the further first engagement portion, is rotationally fixed to the dosing member 23, 332. Exemplarily, the one of the further first engagement portion and the further second engagement portion may be axially fixed to the dosing member 23, 332.
[0462] Exemplarily, the clutch mechanism 113 comprises a first engagement portion which engages a second engagement portion to rotationally secure the nut 38 to the piston rod 44 during dose delivery, wherein the further second engagement portion of the further clutch mechanism 107 forms the first engagement portion of the clutch mechanism 113. This provides a compact construction of the clutch mechanisms 107, 113.
[0463] The nut 38 is exemplarily rotationally fixed relative to the button 18, 318 and / or the dose setting element 22. As an example, the nut 38 is rotationally fixed and axially movable relative to the button 18, 318 and / or the dose setting element 22. It is coupled to the button 18, 318 and / or the dose setting element 22 by a rotation lock. The rotation lock is formed by the nut 38 and one of the button 18, 318 and the dose setting element 22, for example the button 18, 318.
[0464] When the dose delivery mechanism 54, 354 is in the dose setting state, the nut 38 is rotationally movable relative to the piston rod 44, and when the dose delivery mechanism 54, 354 is in the dose delivery state, the nut 38 is rotationally fixed relative to the piston rod 44. Rotation of the nut 38 relative to the piston rod 44 during dose setting results in axial movement due to the threaded connection between the nut 38 and the piston rod 44. By rotationally locking the nut 38 to the piston rod 44 during dose delivery, the threaded connection between the nut 38 and the piston rod 44 is blocked, and the nut 38 and the piston rod 44 become axially fixed relative to each other.
[0465] The nut 38 is rotated by the dose setting member 22 during dose setting and performs an axial movement due to the threaded connection with the piston rod 44. The rotation of the nut 38 causes the nut 38 to translate axially in the distal direction along the thread on the piston rod 44 during dose setting and to translate in the proximal direction during dose cancellation. The axial movement of the nut 38 relative to the piston rod 44 defines the axial movement of the piston rod 44 during dose delivery and thus defines the amount of drug expelled during dose delivery.
[0466] Some general comments about this disclosure:
[0467] The second threaded connection 170, 172 may be provided between the driver 36 and the piston rod guide 42. However, there are various other options for providing the second threaded connection 170, 172. For example, a second threaded connection may be provided between the dosing element 34 and the housing 32. The second threaded connection 170, 172 preferably acts between any part rigidly connected to the driver 36 and any part rigidly connected to the housing 32.
[0468] Preferably, the actuation members 18, 20, 22 are coupled to the piston rod 44 via the nut 38 in such a way that during dose delivery, axial movement of the actuation members 18, 20, 22 causes axial movement of the nut 38 and the piston rod 44. In order to apply an axial force from the nut 38 to the piston rod 44 during dose delivery to move the piston rod 44 in the axial direction via the nut 38, the nut 38 forms a first threaded connection with the piston rod 44 via an outer thread 190 that meshes with an inner thread 192. During dose delivery, the nut 38 and the piston rod 44 are prevented from relative rotational movement, so that axial movement of the nut 38 causes axial movement of the piston rod 44.
[0469] With regard to the optional feature that "all parts configured to rotate relative to the housing 32 during dose delivery are connected to the housing 32 by exactly one threaded connection 170, 172", it is pointed out that the dose delivery mechanism 54 may include the driver 36, the dose sleeve 34 and / or the snap element 24. One or more of these parts may be configured to rotate relative to the housing 32 during dose delivery. In addition, the delivery mechanism 54 may have one or more additional components that are configured to rotate relative to the housing 32 during dose delivery. All parts of the delivery mechanism 54 configured to rotate relative to the housing 32 during dose delivery may form a subassembly. The subassembly may form exactly one threaded connection 170, 172 with the housing 32 or any part rigidly connected to the housing 32.
[0470] The coupling means 100, 102 may be formed on the injection button and the snap element 24. However, the coupling means 100 may alternatively be formed on the snap ring 20 or the dose setting knob 22. The coupling means 102 may generally be formed on any part that cannot move axially relative to the housing. A person skilled in the art will appreciate that there are various options for where to place the coupling means 100, 102. If the coupling means 100, 102 is configured to permanently axially lock the dose setting knob 22 to the dose setting device or housing 50, this may be accomplished in a variety of ways, such as by a permanent form-fit connection or by a permanent friction-fit connection.
[0471] Generally speaking, the dose setting mechanism may comprise a clutch connecting the nut 38 to the piston rod 44, wherein the nut 38 is rotationally fixed to the piston rod 44 during dispensing and rotates relative to the piston rod 44 during dose setting. Preferably, during dose setting, rotating the dose setting knob causes rotation of the nut 38 relative to the piston rod 44. There are various ways how to design the connection between the dose setting knob and the nut 38.
[0472] Generally speaking, the piston rod 44 may be rotationally fixed relative to the housing during dose delivery / dispensing.
[0473] The proximal end 14 includes a dispensing outlet. The distal end 12 is disposed at an opposite end of the proximal end 14. The dispensing outlet may include one of a needle, a cannula, and a connection point for a needle or a cannula.
[0474] The cover 16 may cover a portion of the dose delivery activation mechanism that is configured to activate dose delivery. The dose delivery activation mechanism is a portion that is configured to allow a dose to be dispensed from the delivery device. The activation mechanism may include an injection button 18 that forms the distal face of the injection pen. The cover 16 may also cover a dose setting knob 22. Thereby, the cover 16 prevents setting a dose and / or activating an injection before mixing of the two components is complete.
[0475] The delivery condition is a condition in which all parts of the dose delivery mechanism 54 are arranged in the same relative position relative to each other as they were after manufacture of the dose delivery mechanism 54. In other words, the delivery condition is a condition in which the user has not rotated or otherwise changed the position of the dose setting member 34 relative to the housing. Thus, when the user sets a dose, the dose delivery mechanism 54 is no longer in the "delivery condition" but is instead in the "set state". According to one embodiment, in the "delivery condition", the dose setting knob 22 cannot be rotated towards the zero dose position. According to one embodiment, actuation is blocked in the "delivery condition" to prevent accidental activation.
[0476] The dose delivery mechanism may include an activation member 18, a dose setting knob 22, a snap element 24, a dose selector 28 and / or a clip 30. The activation member 18 may be configured to be pushed by a user to initiate an injection process. The snap element 24 is preferably configured to engage with the dose selector 28, preferably at different rotational positions, to define a settable dose. The clip 30 may be used in conjunction with the knob cover 16 to prevent movement of the activation member 18 relative to the housing 32 when the pen falls onto its proximal end 14.
[0477] Reference numerals list
[0478] 1 Proximal direction
[0479] 10 Injection Pen
[0480] 12 Remote
[0481] 14 Proximal
[0482] 16 Knob cover
[0483] 16a Closed perimeter
[0484] 16b Closed surface
[0485] 18 Injection button / adjustment element
[0486] 18a Cylindrical part
[0487] 19 Outer edge
[0488] 20 Clamp / Connector
[0489] 22Dose setting knob / dose setting element
[0490] 23. Quantitative supply component
[0491] 24 snap-on components
[0492] 26 Connectors
[0493] 28 sleeves / dose selector
[0494] 30 Knob key
[0495] 32 Shell
[0496] 32a Surface
[0497] 34 Dose setting sleeve / dosing element
[0498] 36 Driver
[0499] 38 Nut
[0500] 40 Spring
[0501] 42 Piston rod guide
[0502] 43 Connectors
[0503] 44 Piston rod
[0504] 45 Distal segment
[0505] 46 piston disc / bearing
[0506] 48 barrels
[0507] 50 cartridge container / drug container
[0508] 52 Barrel Key / Barrel Retainer
[0509] 54 Dose delivery mechanism
[0510] 56 Pharmaceutical Reconstitution Unit
[0511] 58 Wing
[0512] 60 Lugs
[0513] 62 Window
[0514] 64 bulge
[0515] 66 Adjacent part
[0516] 66a Front surface
[0517] 68 incision
[0518] 69 Chamfered part
[0519] 70 Axial abutment protrusion
[0520] 72 Gap
[0521] 74 Linear recess
[0522] 76 Anti-roll device
[0523] 78 Anti-roll device
[0524] 80 front surface
[0525] 81 Axial lock
[0526] 82 Axial fixing device
[0527] 84 Ribs
[0528] 86 Axial fixing device
[0529] 88 Undercut
[0530] 89 Rotation Lock
[0531] 90 Rotation Fixture
[0532] 92 Rotating fixture
[0533] 93 Toothed part
[0534] 94 Rotating Fixture
[0535] 96 Rotating Fixture
[0536] 97 Locking mechanism
[0537] 98 Assembly device
[0538] 98a Locking part
[0539] 98b Another locking part
[0540] 100 Coupling device
[0541] 100a Chamfered surface
[0542] 101 Incision
[0543] 102 Coupling device / locking corresponding part
[0544] 104 Ribs
[0545] 106 slots
[0546] 107 Clutch mechanism
[0547] 108 teeth
[0548] 110 teeth
[0549] 112 Coupling surface
[0550] 114 teeth
[0551] 115 Dose Limitation Agency
[0552] 116 Engagement feature
[0553] 118 Dose stop
[0554] 118a Dose stop
[0555] 118b Dose stop
[0556] 118c Dose stop
[0557] 118d Dose stop
[0558] 120 elastically deformable section
[0559] 121 incision
[0560] 122a-d side surface
[0561] 123a-d side surface
[0562] 124 Hard stop
[0563] 126 Hard stop
[0564] 128 Hard stop
[0565] 130 Opening
[0566] 132 Notch
[0567] 134 Ribs
[0568] 136 Protrusion
[0569] 136a Chamfered surface
[0570] 138 Ribs
[0571] 140 slots
[0572] 142 Axial fixing device
[0573] 144 Entrance
[0574] 146 Axial fixing device
[0575] 148 Rotating Fixture
[0576] 150 Rotating fixture
[0577] 152 Rotating fixture
[0578] 154 Rotating Fixture
[0579] 156 Ribs
[0580] 158a Incision
[0581] 158b Incision
[0582] 158c incision
[0583] 158d incision
[0584] 160 Nearside edge
[0585] 162 Distal edge
[0586] 164 Keep Protruding
[0587] 166 Window
[0588] 168a Tags
[0589] 168b Tags
[0590] 168c Tags
[0591] 168d Tags
[0592] 168e Tags
[0593] 169a Non-circular outer surface
[0594] 169b Non-circular inner surface
[0595] 170 External thread
[0596] 171 Fixed section
[0597] 172 Internal thread
[0598] 173 Surface
[0599] 174 End Stops
[0600] 176 End Stop
[0601] 177 Attachment
[0602] 178 Axial fixing device
[0603] 179 Attachment
[0604] 180 Axial fixing device
[0605] 182 Rotating Fixture
[0606] 184 Rotating Fixture
[0607] 186 Opening
[0608] 188 Section
[0609] 189 Threaded connection
[0610] 190 External thread
[0611] 192 Internal thread
[0612] 194 Pressing surface
[0613] 196 front surface
[0614] 198 Coupling device
[0615] 200 Coupling device
[0616] 202 First Chamber
[0617] 204 Second Chamber
[0618] 206 Bypass
[0619] 208 first sealing element
[0620] 210 Second sealing element / plunger
[0621] 212 Axial fixing device
[0622] 214 Axial fixing device
[0623] 216 Rotating Fixture
[0624] 218 Rotating Fixture
[0625] 220 Window
[0626] 221 Incision
[0627] 222 Window
[0628] 223 Notch
[0629] 224 Thread
[0630] 226 End surface
[0631] 228 Surface
[0632] 230 First thread
[0633] 232 Second thread
[0634] 234 snap-on components
[0635] 236 Opening
[0636] 238 Opening
[0637] 240 Opening
[0638] 242 Displacement Section
[0639] 244 Radial end stop
[0640] 246 External surface
[0641] 248 Interior Space
[0642] 249 Keeping section
[0643] 250 Bias element
[0644] 252 Opening
[0645] 254 Inner surface
[0646] 256 External surface
[0647] 258 Ring Space
[0648] 260 inner peripheral surface
[0649] 262 Peripheral surface
[0650] 264 Peripheral surface
[0651] 266 End face
[0652] 268 End face
[0653] 300 Drug Delivery Devices
[0654] 301 Cap
[0655] 305 Container Holder
[0656] 306-pin connector
[0657] 307 Connector
[0658] 318 Adjustment element
[0659] 323 quantitative supply component
[0660] 332 Shell
[0661] 333 Upper shell part
[0662] 334 quantitative supply element
[0663] 335 threaded connection
[0664] 336 Driver
[0665] 337 Another thread connection
[0666] 342 Piston rod guide
[0667] 343 Connector
[0668] 348 Drug Container
[0669] 349 Needle End
[0670] 354 Dose delivery mechanism
[0671] 500 Drug Delivery Devices
[0672] 501 Needle Assembly
[0673] 502 Casing
[0674] 503 needle cap
[0675] 504 Cap
[0676] 505 Container Holder
[0677] 506 Connector
[0678] 507 Clutch
[0679] 508 First Clutch Section
[0680] 509 Second clutch part
[0681] 513 Clutch Mechanism
[0682] 514 teeth
[0683] 515 teeth
[0684] 518 Adjustment element
[0685] 520 Coupling element
[0686] 523 quantitative supply component
[0687] 524 coupling member
[0688] 525 Extension
[0689] 527 Connector
[0690] 528 Sleeve
[0691] 528a External part
[0692] 529 Locking corresponding part
[0693] 530 Another locking corresponding part
[0694] 532 Housing
[0695] 533 Retaining lug
[0696] 534 Shell Window
[0697] 535 Opening
[0698] 543 Connector
[0699] 554 Dose delivery mechanism
[0700] 560 Rotatable Fixing
[0701] 561 Circular Edge
[0702] 562 Thread
[0703] 563 Rotating Fixing
[0704] 564 longitudinal ridge
[0705] 566 Lug
[0706] 567 Opening
[0707] 568 Radial stop
[0708] 569 Stop surface
[0709] 570 Rotatable Fixing
[0710] 571 Circular Edge
[0711] 573 Opening
[0712] 575 Ridge
[0713] 580 End Plate
[0714] 582 bars
[0715] 584 Axial fixing
[0716] 585 Rotating Fixing
[0717] 586 recess
[0718] 587 Paw
[0719] 590 recess
[0720] 592 Edge
[0721] 597 Locking mechanism
[0722] 599 Another locking mechanism
[0723] 600 Locking part
[0724] 610 Window
[0725] 612 Thread
[0726] 614 Opening
[0727] 616 Ridge
[0728] 618 concavity
[0729] 620 Connector
[0730] 622 Lug
[0731] 624 recess
[0732] 626 Circular Edge
[0733] 630 Lug
[0734] 632 Ridge
[0735] 634 Proximal blocking element
[0736] 635 Distal blocking element
[0737] 636 Stop surface
[0738] 700 Drug Delivery Devices
[0739] 720 Coupling element
[0740] 754 Dose delivery mechanism
[0741] L1 Length
[0742] L2 Length
[0743] W1 Width
[0744] W2 Width
Claims
1. A cartridge holding unit, comprising: a cartridge container (50) which forms an outer surface (246) of the cartridge holding unit and has an inner space (248), and a cartridge holder (52) forming a tubular holding section (250) arranged in the interior space (248) of the cartridge container (50), wherein the cartridge holder (52) is configured to, in particular, securely hold the cartridge (48) parallel to the cartridge holder (52), and Therein, the cartridge holder (52) and the cartridge container (50) are coupled to one another in particular firmly in their axial orientation.
2. The cartridge holding unit according to embodiment 1, in, The cartridge container (50) and the cartridge holder (52) are formed as two separate parts.
3. The cartridge holding unit according to embodiment 2, in, The cartridge container (50) and the cartridge holder (52) are inseparably coupled to each other.
4. The cartridge holding unit according to any one of the preceding embodiments, in, The cartridge container (50) and the cartridge holder (52) are axially fixedly connected to each other.
5. The cartridge holding unit according to embodiment 4, in, The cartridge container (50) and the cartridge holder (52) are axially fixedly connected to each other by a form-locking engagement, for example by a snap-fit connection.
6. The cartridge holding unit according to any one of the preceding embodiments, in, The cartridge container (50) and the cartridge holder (52) are securely coupled to each other with respect to their axial orientation by a form-locking engagement, such as by a snap-fit connection.
7. The cartridge holding unit according to any one of the preceding embodiments, in, The cartridge holder (52) forms an axial fixing means (212) which engages with an axial fixing means (214) of the cartridge container (50), Wherein, for example, one of the axial fixing devices (212, 214), such as the fixing device of the cartridge holder (52), is constructed as a circumferentially extending groove, and the other of the axial fixing devices (212, 214), such as the fixing device of the cartridge container (50), is constructed as a circumferentially extending rib.
8. The cartridge holding unit according to any one of the preceding embodiments, in, The cartridge holder (52) and the cartridge container (50) are rotationally fixed to each other.
9. The cartridge holding unit according to embodiment 8, in, The cartridge holder (52) forms a rotational fixture (216) that engages a rotational fixture (218) of the cartridge container (50).
10. The cartridge holding unit according to embodiment 9, in, The cartridge holder (52) and the cartridge container (50) are rotationally fixed to each other by a form-fitting engagement between the fixing means (216) of the cartridge holder (52) and the rotation fixing means (218) of the cartridge container (50), Wherein, for example, one of the rotational fixing devices, such as the rotational fixing device (216) of the cartridge holder (52), is constructed as a radially protruding rib, and another of the rotational fixing devices, such as the rotational fixing device (218) of the cartridge container (50), is constructed as a radially extending groove for receiving the rib.
11. The cartridge holding unit according to any one of the preceding embodiments, in, The cartridge holder (52) is formed with a needle connector at its proximal end (14), such as threads (224).
12. The cartridge holding unit according to embodiment 11, in, The needle connector surrounds an opening (252) at the proximal end of the cartridge holder (52), Wherein the opening (252) is configured to receive a needle in fluid connection with the interior of the cartridge (48) inserted into the cartridge holder (52).
13. The cartridge holding unit according to any one of the preceding embodiments, in, The cartridge holder (52) forms a slot (223) extending in the axial direction, which slot (223) allows reversible widening of the cartridge holder (52) for axial insertion of a cartridge (48), such as a dual-chamber cartridge (48) with a bypass (206).
14. The cartridge holding unit according to embodiment 13, in, The notch (223) extends to the distal end of the cartridge holder (52).
15. The cartridge holding unit according to any one of the preceding embodiments, in, When the cartridge holder (52) is securely coupled to the cartridge container (50), a window (220) formed in the cartridge holder (52) is aligned with a window (222) in the cartridge container (50), such that a cartridge (48) disposed within the cartridge holder (52) can be observed through the windows (220, 222).
16. The cartridge holding unit according to any one of the preceding embodiments, in, The retaining section (250) of the cartridge retainer (52) defines a cylindrical socket.
17. The cartridge holding unit according to any one of the preceding embodiments, in, The inner surface (254) of the cartridge holder (52) is configured to contact an area of a cartridge (48) inserted into the cartridge holder (52).
18. The cartridge holding unit according to any one of the preceding embodiments, in, The cartridge holder (52) forms a cutout (221) for receiving a protrusion of an inserted cartridge (48), such as the bypass (206) of a dual chamber cartridge (48).
19. The cartridge holding unit according to embodiment 18, in, The cutout (221) is positioned circumferentially offset from the longitudinal slot (223) of the cartridge holder (52), for example, radially opposite to the longitudinal slot (223) of the cartridge holder (52).
20. The cartridge holding unit according to embodiment 18 or 19, in, The cutout (221) is configured as a window in the tubular holding section (250).
21. The cartridge holding unit according to any one of embodiments 18 to 20, in, The boundaries of the cutout (221) are configured to completely surround the protrusion on the outer surface (256) of the inserted cartridge (48) to prevent rotation of the cartridge (48) about its longitudinal axis and / or axial movement of the cartridge (48) along the longitudinal axis.
22. The cartridge holding unit according to any one of the preceding embodiments, in, The retaining section (250) is configured to extend over at least 50% of the longitudinal length of the inserted cartridge (48).
23. The cartridge holding unit according to any one of the preceding embodiments, in, The cartridge holder (52) has connection means for connecting to a dosing mechanism, such as a dose setting mechanism (54).
24. The cartridge holding unit according to embodiment 23, in, The connection means comprises a thread, such as an internal thread (230).
25. The cartridge holding unit according to embodiment 23 or 24, in, The connection means extends into an annular space (258) between the cartridge holder (52) and the cartridge container (50).
26. A cartridge unit comprising a cartridge holding unit according to at least one of the preceding embodiments and a cartridge (48), for example a dual-chamber cartridge (48) with a bypass (206), inserted into the cartridge holder (52).
27. A recombination unit (56), comprising: The cartridge holding unit according to at least one of the preceding embodiments, and a connecting section of the dosing mechanism, such as a piston rod guide (42), In which, the barrel container (50) forms a first thread (230), and the connecting section of the quantitative supply mechanism forms a corresponding second thread (232), and the first thread (230) and the second thread (232) can engage with each other to cause the barrel container (50) to move axially relative to the connecting section of the quantitative supply mechanism by rotating the barrel container (50) relative to the connecting section of the quantitative supply mechanism.
28. The recombination unit (56) according to embodiment 27, in, The first thread (230) is formed on an inner peripheral surface (260) of the cartridge container (50), and the second thread (232) is formed on an outer peripheral surface (262) of the connecting section of the quantitative supply mechanism.
29. The recombinant unit (56) according to embodiment 27 or 28, in, The recombination unit comprises a barrel (48) having a protrusion (206), wherein the cartridge holder (52) forms a cutout (221) for receiving the protrusion (206) of the cartridge (48), And wherein the protrusion (206) positively engages the cutout (221) such that the cartridge (48) is axially and / or rotationally fixed to the cartridge holder (52).
30. The recombinant unit (56) according to any one of embodiments 27 to 29, in, A space (258) is formed between the outer peripheral surface (264) of the cartridge holder (52) and the inner peripheral surface (260) of the cartridge container (50), so that when the cartridge holder unit or cartridge unit is mounted to the connecting section of the quantitative supply mechanism, the connecting section of the quantitative supply mechanism can be arranged in the space (258) between the outer peripheral surface (264) of the cartridge holder (52) and the inner peripheral surface (260) of the cartridge container (50).
